A Complete Overview of Psilocybin and Depression
Can psilocybin, the active component in magic mushrooms, offer legitimate, lasting relief for people struggling with depression?
Mounting research suggests the answer is a compelling yes.
In recent years, psychedelic mushrooms have shed their stigma as a dangerous drug or relic of counterculture. Psilocybin is now at the forefront of a mental health revolution, with clinical studies demonstrating its potential to help treat depression, especially in individuals who haven’t responded to conventional therapy such as SSRI medication (Mann, 2023).
When paired with psychotherapy and administered in a professionally guided setting, psilocybin offers new hope for those facing depression, leading to lasting changes in mood, perspective, and emotional well-being.
In this comprehensive guide, we’ll explore:
- What psilocybin is, and how it impacts the default mode network
- Understanding the different factors behind depression and how psilocybin can help
- How psilocybin works in the brain and how this supports long-lasting relief from depression
- The psychedelic effects of psilocybin experiences and how this can help depression
- The safety of psilocybin, and who psilocybin isn’t for
- The power of group retreats for psilocybin healing
- Why integration is key for long-term change in depression
- Psilocybin’s legal status and options for accessing it
Psilocybin is a New Hope For Depression
Living with depression can be profoundly debilitating, affecting every aspect of a person’s life – from self-care and personal goals to their ability to maintain meaningful relationships.
Yet over 280 million people globally struggle with some form of depression, including 5% of adults, according to the World Health Organization. In the US alone, an estimated 21 million adults had one major depressive episode in 2021, representing 8.3% of all adults.
While emotional fluctuations and periods of feeling down are part of the normal human experience, depression, which is characterized by prolonged episodes of low mood that lead to disruption in a person’s life, often requires specialized treatment.
Depression can manifest in many ways, but typically involves persistent feelings of sadness or emptiness, a loss of meaning and pleasure, and a sense of hopelessness about the future.
Options for healing for people struggling with depression are limited and offer varying degrees of success. People with depression are often prescribed psychotherapy, which, while effective, isn’t a cure-all. Response rates hover at around 40-50% across therapies (Cuijpers et al., 2021), and it typically takes multiple sessions over several months to achieve benefits (Machado-Vieira et al., 2010).
Psychotherapy can help individuals gain a cognitive understanding of their challenges, acquire tools for symptom management, and assist them in beginning to process past traumas. However, for many cases, it can only take the person so far, and what they require is healing that takes place beyond the rational, conscious mind.
Antidepressant medications like serotonin reuptake inhibitors (SSRIs) can also help relieve depressive symptoms, but research indicates they are overprescribed and used for longer than is necessary (Brisnik et al., 2024).
Around 53% to 64% of people experience a significant reduction in symptoms while using SSRIs (Hirschfield, 1999), and they typically take 6-8 weeks to have a full therapeutic effect. Many patients report side effects, including continual nausea, sexual dysfunction, weight gain, sleep disturbances, and emotional blunting – yet around one in eight Americans use antidepressants.
What’s more, antidepressants don’t address the root cause of an individual’s depression. While they may alleviate symptoms, they typically don’t help individuals understand the origins of their distress or begin the deeper process of emotional healing (Barton et al., 2024) and nervous system regulation to overcome depression.
Meanwhile, studies on psilocybin-assisted therapy show its potential to reduce depression symptoms drastically. One study on people with major depressive disorder (MDD) found that mean depression scores rapidly decreased the day after the psilocybin session and remained low through the four-week follow-up, with 54% of patients in remission one month post-session (Davis et al., 2020).
Another study found that psilocybin-assisted therapy has comparable antidepressant effects to a six-week course of the popular SSRI, escitalopram (Carrhart-Harris et al., 2021). At the six-month mark, researchers found that the psilocybin group had experienced additional psychological benefits compared to the SSRI group, including psychological connectedness, finding meaning in life, and functioning well at work and in society (Erritzoe et al., 2024).
What is Psilocybin? A Brief Overview
Ever heard of “magic mushrooms”? It turns out these psychedelic fungi have a powerful psychoactive compound that can promote profound healing in the body, brain, and mind. Psilocybin is found in over 180 species of mushrooms, with the most common ones being Psilocybe cubensis – also known by common strains such as “golden teachers.”
Psychedelic mushrooms have been used for thousands of years by indigenous people worldwide (Spiers et al., 2024). In Mesoamerica, in particular, Native communities such as the Mazatec people used (and continue to use) psilocybin mushrooms in rituals, to connect with the spirit world, and treat physical ailments.
Psilocybin mushrooms were introduced to Western culture in the 1950s, when American banker R. Gordon Wasson traveled to Oaxaca, Mexico, to participate in a Mazatec psilocybin mushroom ceremony with indigenous curandera Maria Sabina.
Wasson then wrote about his experiences in Life Magazine, which influenced the ensuing counterculture in the US and drove spiritual seekers to travel to Mexico in the 1960s in search of similar ceremonies.
However, the Controlled Substances Act of 1971 put a halt to much of the research into psilocybin and other psychedelics and marked the beginning of the War on Drugs.
After this decades-long freeze, psilocybin research saw an uptick in the early 2000s. Since then, researchers have been exploring the mechanisms, safety, and therapeutic potential of psilocybin, with study results indicating its potential to treat various mental health conditions.

How Psilocybin Impacts the Default Mode Network
Once ingested, psilocybin is rapidly metabolized in the liver into psilocin, which is the active compound responsible for its psychoactive effects, i.e., the psychedelic experience.
Psilocin structurally resembles serotonin, a key neurotransmitter involved in mood regulation, cognition, and perception. Due to this similarity, psilocybin primarily binds to serotonin 5-HT2A receptors, particularly in areas of the brain associated with self-awareness, sensory processing, and emotional regulation.
All of this leads to temporary changes in brain network connectivity. This is especially the case in the Default Mode Network (DMN), which is the part of the brain that is involved with internal mental processes, such as rumination, recalling memories, or thinking about the future.
When the DMN is disrupted during a psilocybin experience, it is said that the ego quietens or, at higher doses, dissolves completely. This leads to users experiencing a sense of interconnectedness with others, the world around them, and new psychological aspects of themselves. The changes evoked by psilocybin within this highly complex brain network potentially play a key role in breaking the thought cycles that are common in depression.
We’ll delve deeper into these mechanisms and how they alleviate depressive symptoms later in the article.
Psilocybin Induces Altered States with Therapeutic Potential
So, what does all of this feel like when you’re under the influence of psilocybin?
When taken in a safe and supportive setting, psilocybin can open the mind to new experiences, facilitate deep emotional breakthroughs, and increase psychological flexibility. Users report profound changes in their perceptions (i.e., visions, thought processes, emotional fluidity), as well as mystical and transpersonal experiences, such as feeling “at one” with the universe and/or the natural world.
At this point, it’s important to distinguish between therapeutic and recreational use. When taken recreationally or without the proper set and setting (i.e., going into the experience with a prepared mindset and in a safe and supportive setting for deep personal exploration), psilocybin carries risks.
Without a safe, well-thought-out set and setting, people can come out of the experience feeling psychologically destabilized. They may also be vulnerable to various types of harm while under the influence of the psychedelic, whether intended or not, such as traumatic intrapersonal or interpersonal experiences.
In this article, we’re referring to therapeutic use and guided administration by trained professionals. Unlike recreational experiences, therapeutic psilocybin journeys include dedicated preparation, navigation, and integration support, helping ensure psychological and physical safety at every step of the way.
Understanding the Multiple Sides of Depression
Depression can come as a result of many different factors. While some people’s depression may be rooted in childhood trauma, others’ may be the result of biological imbalances or sociocultural influences.
It’s vital to recognize this complexity when aiming to treat depression, and to understand why many traditional approaches fall short.
Psychological Factors
Many people who suffer from depression experienced early-life trauma, such as abuse, neglect, or loss. Studies show that going through this kind of trauma increases the chances of developing depression later in life, as it can disrupt emotional development and lead to unhealthy coping mechanisms (Heim & Nemeroff, 2001).
Trauma fosters negative core beliefs about the self and the world, which then can manifest in rumination, persistent inner criticism, emotional suppression, and social withdrawal – all typical depressive symptoms.
Processing and healing early-life trauma can significantly help relieve depression by attacking the root cause of the individual’s psychological struggles, instead of just treating the symptoms.
Sociocultural Factors
Depression may also emerge as a result of intergenerational and societal influences.
For example, research in fields such as epigenetics (Yehuda & Lehrner, 2018) and family systems (Reese et al., 2022) suggests that trauma can be passed on across generations, perpetuating cycles of family dysfunction and vulnerability to depression.
The individualistic structures of modern society also contribute to higher rates of depression. More people than ever are experiencing loneliness and social isolation, both of which are risk factors for depression (Luo, 2022).
Many people develop depression as a result of high-stress external circumstances, such as war (Chudzicka-Czupała et al., 2023), pandemics (Pfefferbaum & North, 20202), economic uncertainty (Sarı et al., 2024), political volatility (El Khoury-Malhame et al., 2024), or discrimination. These large-scale stressors can lead to psychological distress and increased depression rates.
Biological Factors
There are also several biological reasons that a person may experience depression.
Depression is associated with reduced neuroplasticity in the brain (Rădulescu et al., 2021). Neuroplasticity is essentially the brain’s ability to adapt and reorganize based on new inputs and processes. For individuals with depression, reduced neuroplasticity means it’s more challenging to break free from rigid thought patterns and emotional responses. This also prevents the creation of new, healthy patterns of thinking and behavior.
Researchers have also witnessed elevated markers of neuroinflammation in depressed individuals (Han & Ham, 2021). This can disrupt normal brain chemistry and the function of neurotransmitters like serotonin and dopamine, which play a key role in mood regulation (Miller & Raison, 2015).
While it’s been previously widely believed that low serotonin activity is implicated in depression, studies show that this relationship is more complex, and not simply a case of the chemical imbalance inducing depression (Moncrieff et al., 2022).
In fact, many patients don’t respond to serotonin-targeting drugs, and some exhibit normal or elevated serotonin levels.
Current research is navigating a “chicken and egg” problem when it comes to the bidirectional relationships involved in depression. The psychological, sociocultural, and biological factors described above are deeply intertwined. For example, trauma can adversely alter brain structure and function, which in turn affects cognition and emotion. Social isolation can increase brain inflammation (Finley & Schaefer, 2023) and worsen depressive symptoms (Slavich & Irwin, 2014).
These factors then reinforce each other, and it becomes difficult to define which one is the “cause” and which is the “effect.” The self-perpetuating cycles make depression difficult to treat with one-dimensional approaches.
Here’s where psilocybin comes in. The psychedelic essentially acts as a “circuit breaker”, temporarily disrupting rigid brain network activity associated with rumination and self-focus.
Guided psilocybin therapy experiences offer a holistic approach, targeting biological, psychological, and social factors and enabling individuals to break free from the entrenched loops that sustain their depression.

How Psilocybin Works in the Brain and How This Targets Depression
Understanding how psilocybin affects the brain helps explain why it shows such promise in treating depression, especially in cases that haven’t responded to conventional treatment like SSRIs.
As we mentioned above, psilocybin disrupts the default mode network (DMN), which is hyperactive in depression, helping to interrupt pathological thought patterns and rumination cycles (e.g., “I’m worthless” or “Nothing will ever change”).
This quietening of the DMN allows individuals to experience a sense of connection beyond the familiar self and access new ways of thinking that were previously inaccessible.
Psilocybin also promotes global brain connectivity, which is when regions of the brain that don’t usually “talk” to each other can communicate freely. This neural flexibility creates new insights and allows the brain to “reboot” its activity patterns.
Functional MRI scans show that after psilocybin administration, the brain shifts into a more fluid and integrated state (Daws et al., 2022), where thoughts, emotions, and perspectives have settled into a new configuration.
Another way that psilocybin works in the brain is by enhancing neuroplasticity and synaptogenesis. These two processes work in tandem, where the brain’s increased ability to reorganize itself, enabled by neuroplasticity, is facilitated by the promotion of new neural connections, which is enforced through synaptogenesis. This rewiring process is what changes the neurological underpinnings of depression, which is enabled by psilocin and the experiential effects it produces.
Michael Pollan, the author How To Change Your Mind, described this experience as “shaking the snow globe” of the mind, referring to the brain’s ability to form new neural connections, essentially rewiring itself.
Research shows that a single dose of psilocybin promotes rapid neuroplasticity, with various effects lasting for days, weeks, and even months following the administration (Calder & Hasler, 2022). This is often referred to as the “critical period” within which the brain can form new connections, and patients can implement new habits and engage in social learning.
Psilocybin also catalyzes healing by amplifying emotional awareness, which can induce catharsis during the administration session. This can mean that negative beliefs and perceptions, repressed memories, unresolved grief, or existential fears come to the surface, allowing them to be processed and healed.
Many people describe processing long-held traumas and feeling self-compassion, grief, or forgiveness for the first time. Studies suggest that the intensity of the mystical or emotional experience during a guided psilocybin journey correlates with positive treatment outcomes for depression, highlighting the importance of these emotional and spiritual breakthrough moments (Brudner et al., 2025).
The Role of the Psychedelic Experience in Treating Depression
With psilocybin showing such immediate influence on brain activity, many have asked whether they can still receive therapeutic benefits without the psychedelic experience.
In other words, “Do I have to ‘trip’ to experience psilocybin’s antidepressant effects?”
Research suggests that the psychedelic effects play an essential role (Yaden & Griffiths, 2020).
While studies in mice show that there are some antidepressant effects without the full “trip”, data are lacking on how this would work for humans (Hesselgrave et al., 2021).
Research on the acute effects of psilocybin—in particular, the mystical experience, ego dissolution, and emotional breakthroughs that people can experience—shows them to be important for achieving mental health improvements.
In one study on major depressive disorder, the “mystical experience” and “ego dissolution” felt during the psilocybin session were uniquely linked to how much a person’s depression improved after treatment (Weiss et al., 2024). This paper also found that psilocybin-induced mystical experience has been associated with an improvement in life quality, meaning in life, and mood in people struggling with anxiety and depression (McCulloch et al., 2022).
Research also shows that emotional breakthrough is a crucial part of the acute psychedelic experience and a key mediator in long-term psychological improvements (Roseman et al., 2019). While mystical experiences are impactful, studies indicate that psychological insights and emotional breakthroughs may be just as, or more, important for achieving positive mental health changes (Kangaslampi, 2023).
The psychedelic effects are also crucial for those working through past traumas. Trauma happens as a felt experience, and we often need a new experience to “undo” it or rewrite trauma patterns. The emotional catharsis, somatic release, and cognitive reframing that happen during psilocybin therapy sessions can support trauma release and processing.
Psychedelic journeys may also bring up forgotten or repressed memories, allowing the person to become aware and reconcile these memories. Research has shown that an important part of healing in psychedelic therapy is “re-narrating one’s own identity and biographical circumstances” after recovering unresolved traumatic memories (Rose, 2024). We’ll dive into how this works with psilocybin a little later.
What is a Psilocybin Experience Like for Treating Depression?
Depression is often rooted in unresolved psychological challenges, such as trauma, shame, self-blame, or grief. When unaddressed, these feelings can solidify into persistent negative beliefs and mood states.
Here’s where psilocybin can be especially powerful. Research and first-person reports consistently show that the psilocybin experience often induces deep emotional catharsis, or the intense release of suppressed feelings (Griffiths et al., 2016). This is often framed as “purging” or “letting go” of old pain, grief, or shame, and works not only on the level of the psyche, but also somatically, i.e., in the body.
During the psilocybin session, these effects can manifest as crying, shaking, laughing, or even yawning. It’s all normal and part of the process of mental, emotional, and physical release.
As mentioned in the previous section, psilocybin can also bring up repressed memories that have been relegated to the unconscious mind as a protective mechanism. But these memories don’t just disappear – they can manifest as depression, anxiety, or emotional numbness over time.
Psilocybin lowers these internal barriers, bringing memories to the surface in the form of visions, feelings, unfamiliar thoughts, and somatic releases. This phenomenon has even been shown in brain imaging studies.
However, it’s difficult to know whether memories that arise during psychedelic experiences are true repressed events or emerge as metaphors or constructed images (Otgaar et al., 2019). Fortunately, skilled facilitators and integration providers are trained to contextualize these experiences, focusing less on literal accuracy and more on the emotional truth and meaning for the individual.
At the core of psilocybin healing is providing a safe container for the person to explore their inner world, before, during, and after the experience. Part of this involves the set and setting during the journey – the psychological preparedness and mood state going into the session, the physical environment, and the safety and compassion felt in the relationship between journeyer and facilitator.
Another key component is the support that the person receives before and after their experience. Dedicated group or one-on-one preparation support can help an individual clarify their intentions for the journey and gain tools to navigate the challenging aspects of being in an altered state. Once they emerge from the experience, integration sessions can help them make sense of what happened and apply those insights to their everyday life.
Clinical trial protocols have found that therapeutic support before and after psilocybin experiences is vital not only for psychological safety during the session, but also in receiving mental health benefits long after it finishes (Gukasyan et al., 2022).

Is Psilocybin Safe for People with Depression?
Psilocybin has been shown to help those with major depressive disorder, treatment-resistant depression, or more minor forms of depressive disorders.
But you may be wondering, is psilocybin safe for everyone with depression?
When administered in safe environments with skilled practitioners, psilocybin has an excellent safety profile (Gukasyan et al., 2022). There is no known legal dose in humans, in stark contrast to many common medications and recreational substances.
Adverse effects during the acute experience, such as nausea, anxiety, headache, dizziness, or vomiting, are transitory and usually resolve within a day. These symptoms are best seen as part of the working-through process rather than “side effects” to mitigate.
There are, however, individuals who shouldn’t use psychedelics (Johnson et al., 2008). Those with a personal or family history of psychotic disorders (such as schizophrenia or bipolar disorder) are more likely to have a destabilizing experience.
Psilocybin is also not a replacement for emergency care in the case of active suicidal ideation. Ketamine is a better alternative in these scenarios due to its reliable, quick-acting effects (Pan et al., 2023).
Any psilocybin practitioners must conduct a thorough intake to understand the full psychological history of their participants and screen out vulnerable candidates.
Long-term adverse outcomes from psilocybin most often happen as a result of unsupervised, mismanaged, or recreational use, not from therapeutic settings. While there will always be some inherent risk to high-dose psychedelic journeys, this is remarkably low when expert care is present, such as in psilocybin therapy sessions with trained, experienced mental health practitioners.
Psychedelic Integration for Depression Turns Insight into Long-Term Change
Psychedelic integration is the process of integrating the psychedelic experience into your everyday life (Bathje et al., 2022). Psilocybin catalyzes altered states that individuals need to reflect on, process, and apply in the aftermath of the experience—this is the integration period.
The first part of integration is understanding your experience and its meaning for your healing journey. This might look like unpacking your experience verbally with a therapist or coach, or in an integration circle. By giving words to the experience, people are often able to draw more meaning from it and deepen their understanding of what came up.
Then, with this information in hand, you can transform it into action. For example, a person who connects with a sense of profound self-love and self-worth during their psilocybin session might decide to take better care of themselves by nourishing their body with healthy foods or introducing a mindful movement practice into their daily routine.
While integration absolutely can (and usually does) involve lifestyle changes, it’s not simply a to-do list of implementing new practices—it’s a process of embodiment, transformation, and perspective change that takes place on the levels of the mind, body, and spirit. Ongoing conscious behavioral change, mindfulness, specialized integration support, and somatic practices can help deepen and ground the experience into your everyday life with time.
For individuals with depression, proper integration can make the difference between a short-term reduction in symptoms and concrete, long-term positive changes. While the days and weeks post-psilocybin bring a window of neuroplasticity and “afterglow”, this wears off—and it’s the work the individual puts in to apply the lessons of their experience that will create lasting change.
Why Psilocybin Retreat Settings May Enhance Healing
When it comes to psilocybin journeying, there are generally two options that offer a safe, supportive experience: a one-on-one guided session or a retreat setting.
While many people have seen powerful results from clinical approaches, group retreat settings bring additional, profound benefits.
Nature Connection
Many retreats are set in natural environments, which are proven to help reduce depression and provide a welcome break from overstimulating urban settings (Balanzá-Martínez & Cervera-Martínez, 2022). This connection to nature during a retreat supports nervous system regulation and can deepen the healing that takes place (Gladwell et al., 2012).
Multi-Day Immersive Format
Retreat settings offer a focused, extended setting for healing. Over several days, participants step away from everyday distractions and immerse themselves fully in the therapeutic process, while multiple psilocybin sessions allow for deeper emotional exploration. This extended arc supports a transformational journey, often likened to a “Hero’s Journey”, where individuals confront inner challenges and emerge with renewed clarity, strength, and purpose.
Group Support
Psilocybin healing is deep work, and we’re not meant to go through it alone. The group dynamics during retreats create a safe, supportive container, allowing participants to connect with and learn from each other both organically and during facilitated sharing circles. Social connection is invaluable for many people struggling with depressive symptoms, and going through a challenging experience together can help them form deep, social bonds and find relief from the isolation that often accompanies depression (Wickramaratne et al., 2022).
The research supports the value of retreat settings for psychedelic healing, too. In one study, a group of adults who were mistreated as children experienced a reduction in trauma symptoms and trait shame after taking psychedelics in an intentional group setting (Healy et al., 2025).
Another study on veterans found that psilocybin and ayahuasca retreats resulted in significant improvements to their mental well-being, quality of life, PTSD, anxiety, and depression (Calnan et al., 2025).
Where and How Can You Receive Legal Psilocybin Treatment for Depression?
Psilocybin access worldwide continues to evolve, with a patchwork of legal frameworks shaping therapeutic availability. Here’s an overview of where and how you can receive psilocybin treatment.
Legal psychedelic retreats in Jamaica and the Netherlands
Both Jamaica and the Netherlands are popular destinations for psilocybin retreats. In Jamaica, there are no laws specifically outlawing psilocybin mushrooms, making them legal for cultivation, sale, and consumption.
The Netherlands allows the sale and supervised consumption of psilocybin truffles (which are the sclerotia from certain mushroom species) while prohibiting psilocybin mushrooms themselves.
Retreat centers in both Jamaica and the Netherlands offer guided experiences in a legal, controlled environment, attracting international visitors who are unable to access the therapy in their home state or country.
Psilocybin for Depression in the USA
In the US states of Oregon and Colorado, residents can access guided psilocybin therapy through legal frameworks.
Oregon became the first state to launch regulated psilocybin services in 2023, and as of 2025, dozens of licensed service centers operate statewide. Adults over the age of 21 can access psilocybin in supervised, non-medical settings, with trained facilitators providing preparation, oversight, and integration support.
Colorado also legalized psilocybin and other plant-based psychedelics for supervised adult use. Both clinical and non-clinical trained facilitators can now provide psilocybin therapy in licensed healing centers across the state.
Accessing Psilocybin Therapy for Depression in Canada
In Canada, patients with serious or life-threatening conditions can apply for access to psilocybin therapy through Section 56 exemptions. The Special Access Program also allows healthcare providers to request psilocybin for patients suffering from conditions not manageable with conventional treatments.
However, access hasn’t been easy for many of the Canadians seeking psilocybin treatment through this program, with some patients suing the government over delayed access.
Limitations of Underground Therapy
In countries or states where psilocybin remains illegal, many individuals seek out underground practitioners. While some underground facilitators can provide skilled support, the lack of regulation introduces risks.
There’s no way to verify facilitator expertise, and often, there’s insufficient screening and psychological support, as well as no legal recourse in case harm is caused. Without the oversight of an above-ground model, preparation, facilitation, and integration standards vary widely, heightening the risk of adverse or traumatic outcomes.
Meanwhile, legal, regulated centers provide medical and psychological screening, professional facilitators, accurate dosing, and structured integration—factors proven to increase the safety and effectiveness of psilocybin therapy.
There’s also no legal risk for pursuing healing when taking the regulated route. This peace of mind is essential for undertaking meaningful therapeutic work.
Why Choose MycoMeditations to Treat Depression with Psilocybin Therapy?
If you’re seeking psilocybin treatment for depression, a MycoMeditations psilocybin retreat might be just what you’re looking for.
Our unique approach is designed to help you achieve lasting mental health improvements, combining traditional knowledge with cutting-edge research and evidence-based therapeutic modalities. MycoMeditations is designed to be the most therapeutically rigorous psychedelic retreat in the world.
Experienced licensed therapists and facilitators accompany you to ensure you feel safe and supported from the moment you sign up. We provide individualized care throughout the retreat and follow-up, structured integration sessions so you can maximize your chances of creating real, lasting change and finding relief from depression.
The data we have gathered over multiple years has shown that the MycoMeditations psilocybin-assisted retreat model provides comparable positive treatment outcomes for depression as shown in clinical trials, with clinically significant improvements in depression maintained one year after the retreat.
Curious about what our guests have to say? Read about their experiences on our testimonials page.
Psilocybin and the Path Forward into a New Depression Treatment
As we’ve explored throughout this guide, the science behind psilocybin is robust, evolving, and remarkably promising.
Clinical trials, brain imaging studies, and firsthand accounts all point to the same conclusion: psilocybin, when administered with care and paired with therapeutic support, has the potential to bring deep, lasting relief to those suffering from depression.
At its core, psilocybin therapy extends beyond the realm of biochemistry and brain scans. It’s about transformation. Psilocybin helps individuals to reconnect with their emotions, rewrite painful narratives, and release what no longer serves them, so they can break free from depression and cultivate a life of joy and purpose.
We are in the midst of a renaissance in mental health care—one that embraces holistic approaches to healing and the wisdom of altered states. We genuinely believe that psilocybin is at the center of this movement, not as a miracle cure, but as a powerful catalyst for change when used with intention, safety, and integration.
Psilocybin represents a turning point for so many struggling with debilitating mental health symptoms—a return to a sense of wholeness and hope.
If you’re struggling with depression and are curious whether a psilocybin-assisted retreat might be right for you, explore our programs at MycoMeditations.
A Complete Overview of Psilocybin and Anxiety
If persistent fear and worry crowd your day, even when you’re completely safe, you’re not alone.
Anxiety levels are on the rise. It’s estimated that over 300 million people globally and 19% of the US population suffer from an anxiety disorder.
Anxiety is one of the most common mental health struggles in the Global North, profoundly impacting sufferers’ daily lives, psychological well-being, and physical health.
And while traditional treatments may help many people, not everyone finds lasting relief.
This gap is why researchers – and a growing number of patients – are paying close attention to psilocybin, the compound in magic mushrooms. Early clinical studies and real-world reports point to meaningful reductions in anxiety thanks to the neurological changes, psychological insights, and mystical experiences that occur during the psilocybin journey.
In this guide, you’ll learn:
- Types of anxiety: GAD, SAD, and End-of-Life Anxiety
- What psilocybin is and how it works in the brain
- What the research shows so far on anxiety and related conditions
- What the experience is like for anxious minds (before, during, after)
- Preparation, set & setting, and integration
- Vetting practitioners and finding the right center for you
- Real insights from guests on using psilocybin to work with anxiety
Different Types of Anxiety Disorders
Anxiety can show up across a range of mental health disorders, including panic disorders, OCD, and eating disorders. In this article, we’ll focus primarily on two of the most common types of anxiety disorders: generalized anxiety disorder (GAD) and social anxiety disorder (SAD).
Generalized Anxiety Disorder
GAD involves chronic, excessive worry about everyday events across multiple domains, such as health, finances, or work. Think your typical type of anxiety, where you spend a disproportionate amount of time stressed about things that haven’t happened yet, and likely never will.
Sufferers often experience physical symptoms like restlessness, muscle tension, sweating, and palpitations, and feel a sense of dread or irritability. GAD may also worsen other physical health conditions like digestive issues, headaches, and chronic pain.
There are several potential causes of GAD. Some studies have found that genetics play a role, as well as neurobiological factors, such as dysregulation in the hypothalamic–pituitary–adrenal (HPA) axis and heightened amygdala reactivity.
People who are less tolerant of uncertainty are more prone to develop GAD, in addition to those who are going through chronic stress (such as financial or relationship stress), and have experienced trauma earlier in life.
In fact, studies have found that trauma can inhibit the amygdala (the part of the brain that kicks us into survival mode) from telling the difference between current and past threats.
Social Anxiety Disorder
Social anxiety disorder (SAD) involves disproportionate anxiety about social situations and fear of scrutiny by others. It often shows up physically as blushing, trembling, sweating, or nausea during or in anticipation of social exposure.
Those who suffer from social anxiety often fear negative evaluation in social situations and may struggle with interpersonal functioning and building new relationships with others.
Research indicates that children who show signs of behavioral inhibition (BI), i.e., apprehension and discomfort around new places, people, and activities, are at a higher risk of developing anxiety disorders later in life.
This is especially the case for those who have high BI and over-protective or anxious parents or caregivers, and those who experienced trauma around social situations, such as bullying.
Hyperactivation in the amygdala and insula (which supports emotional processing, integrating bodily states, and nervous system regulation) is associated with SAD. Social anxiety is also more likely to show up in people who consistently think negatively of themselves and their capabilities.
End-of-Life Anxiety
While we’ll focus primarily on GAD and SAD in this article, it’s important to mention end-of-life anxiety, given the amount of research on how sufferers may find relief through psilocybin.
End-of-life anxiety refers to debilitating fears and worries about one’s own mortality and the dying process. The causes of this are clear – being confronted with the prospect of dying, while also dealing with physical decline and symptom burden, can trigger intense feelings of distress.
People who are going through end-of-life anxiety may experience excessive rumination, a sense of helplessness, or regrets about their life choices. They may also feel worried about being a burden on others.
What is Psilocybin and How Does it Work in the Brain?
In recent years, psilocybin has gone from a stigmatized “drug” that’s taken by hippies to a scientifically recognized breakthrough mental health treatment.
But its therapeutic use goes back much further than the clinical trials of the last few decades. Psilocybin mushrooms have been used ceremonially in indigenous communities across the world for centuries. For example, Mexican groups like the Mazatecs and Zapotecs use one of the psilocybin mushrooms in rituals for healing and spiritual divination called Veladas.
So, how does this sacred mushroom work in our brains?
Many of the therapeutic effects of psilocybin come from its activation of serotonin 5-HT2A receptors, which are found in the brain regions responsible for emotional processing.
When ingested, psilocybin is rapidly converted into its active metabolite psilocin, which, when bound to 5-HT2A receptors, initiates neurobiological changes that underlie both the acute psychedelic experience and long-term therapeutic benefits.
Psilocybin is known to promote neuroplasticity – the brain’s capacity to form new neural connections. This makes it easier for individuals to create new habits and thought patterns in the days and weeks following the psilocybin experience, acting as a neurological “fresh snowfall” on the mind.

Psilocybin also dramatically alters brain network connectivity, particularly within the default mode network (DMN). The DMN refers to the brain regions associated with self-referential thinking and rumination – i.e., overthinking about things that have happened in the past or are yet to happen.
Studies show that psilocybin essentially loosens the tight coupling of regions in the DMN during the acute experience, helping to tune down rumination and self-talk. In the days and weeks following the experience, this DMN “reset” is thought to be responsible for therapeutic effects in patients with depression and anxiety.
Psilocybin For Anxiety: What Does the Research Say?
While the research may not be as extensive as psilocybin for depression, published and ongoing studies suggest that it has the potential to treat various anxiety disorders.
The most direct evidence for psilocybin as a treatment for GAD comes from Incannex Healthcare’s midstage clinical trial involving 73 participants with generalized anxiety disorder. In this randomized, placebo-controlled study:
- Anxiety scores decreased 12.8 points in the psilocybin group versus 3.6 points in the placebo group at 11 weeks
- 44% of psilocybin-treated patients experienced anxiety score reductions of more than 50% – over four times higher than placebo
- 27% achieved full disease remission, more than five times higher than controls
- Treatment was well-tolerated with no serious adverse events
This review of clinical trials showed that psilocybin administration resulted in a sustained reduction in symptoms of depression and anxiety. Patients also saw an enhanced sense of well-being, life satisfaction, and positive mood up to six months after the psilocybin treatment.
Another study demonstrated that psychedelics, including psilocybin, helped reduce anxiety and increase self-perception and social function in patients with GAD, SAD, or anxiety related to another medical condition.
This meta-analysis of four studies also showed significant reductions in anxiety and depression symptoms post-psilocybin treatment and at the six-month follow-up. Meanwhile, this study found that when combined with mindfulness meditation, psilocybin therapy disrupts the neural mechanisms that underlie social anxiety disorder, helping sufferers regulate self-referential processing and experience unbiased perception of social situations.
Data gathered from our retreat guests at MycoMeditations indicates that psilocybin-assisted therapy can provide lasting relief for people suffering from generalized anxiety disorder and/or social anxiety.
The data showed clinically significant, durable improvements in both GAD and SAD symptoms one year after the retreat, and highlighted the utility of group psilocybin retreats for people with anxiety disorders, when supported by individual therapy.
Overlap of Study Results
Many of the studies on depression also note an improvement in anxiety. This means that the researchers weren’t necessarily looking at the effect of psilocybin on anxiety, but they noticed an improvement in anxiety symptoms.
For example, in a study of people with terminal cancer, psilocybin improved their anxiety as well as depression and overall mood. Another study looking at the effects of psilocybin on people with depression saw an improvement in both anxiety and depression.
There’s also some early research on the effects of psilocybin on obsessive-compulsive disorder (OCD). Even though the study didn’t look at psilocybin’s effects on anxiety specifically, anxiety is a major component of OCD. And in this study, psilocybin showed a reduction in anxiety symptoms of OCD.
Research on End-of-Life Anxiety and Psilocybin
While cancer and terminal-illness related studies are not the primary focus of this article, they provide crucial evidence of psilocybin’s potential to treat anxiety. Multiple large randomized controlled trials in cancer patients with anxiety disorders have demonstrated substantial therapeutic benefits:
This landmark Johns Hopkins study examined 51 cancer patients with life-threatening diagnoses and anxiety/mood symptoms. Results showed:
- HAM-A anxiety scores decreased significantly (d=3.40) at 6-month follow-up
- 83% overall response rate for anxiety at 6 months
- 57% achieved anxiety symptom remission
- Effects correlated strongly with mystical experience intensity
Another study conducted at NYU Langone found that psilocybin-assisted psychotherapy significantly reduced anxiety in cancer patients, with improvements lasting up to six months. The study concluded that psilocybin therapy benefits may extend far beyond previously understood applications.
The Psilocybin Experience for People With Anxiety
If you’re somebody struggling with anxiety, you may be wondering if a psilocybin experience would be too much for you to handle, or even make your anxiety worse.
While feelings of fear and anxiety can come up during a psilocybin session – this is normal – and several factors contribute toward you feeling safe, supported, and grounded during the experience.
If you have been taken through a thorough screening and preparation process and have the right “set and setting” going into the session, along with ample integration support available afterwards, the likelihood of you having an experience that causes any psychological harm is extremely low.
Before: Screening, Preparation, and Set & Setting
The first step of having a safe psilocybin experience is screening. This is important because psilocybin is not a good fit for everyone – for example, individuals with psychotic disorders, bipolar disorder, or uncontrolled cardiovascular disease should not take psilocybin.
Certain medications are absolutely contraindicated with psilocybin, such as lithium, and other drugs, such as SSRIs, will likely blunt the psychedelic experience significantly. If you are taking SSRIs and are planning to taper off before a psilocybin session, make sure to do so under the supervision of a licensed medical or mental health professional.
Other aspects of screening include assessing psychological stability, psychological background, physical health, self-awareness, coping skills, and understanding any other therapeutic modalities that you may have explored and their results. If you are struggling with an anxiety disorder, it’s helpful to have explored some kind of talk therapy or other healing practices before embarking on a psychedelic experience. Having done previous inner work will help you navigate the psychological material that comes up during your psilocybin session.
Once you pass the screening, you will be taken through a process of preparing psychologically for the experience. This refers to the mindset in set and setting.
A key aspect of preparation involves clarifying your intentions – what do you want to gain from the experience? What specifically do you want to work on changing? How do you plan to approach the experience?
Try to have between one and three clear, specific intentions you want to work on. For example, “help me accept myself fully,” or “remain open to all that is shown to me.” The ideal intention will apply to any type of experience that may arise, and with psilocybin, this range can be vast.
Practices such as somatic therapies, yoga, meditation, breathwork, and spending time in nature will all help you cultivate the tools to traverse your psilocybin session. Developing your mind-body connection will help you feel more grounded and regulated, should anxiety arise during your session.
The setting in set and setting refers to the environment around you. This incorporates the physical space you’re in and the people around you – you want to prioritize feeling safe and comfortable. Ideally, you’ll also have access to nature. Setting also includes the sounds or music you can hear during your journey.
Especially when taking part in group psilocybin sessions, you may feel a sense of bonding or camaraderie with the other people also taking part. And of course, having trained facilitators there to take care of you is a crucial component of having a safe experience.
During: What the Psilocybin Experience Can Feel Like
So, you’ve selected a trustworthy practitioner, gone through a screening process, and followed the necessary preparation guidelines. It’s time for your psilocybin journey.
Once you ingest the psilocybin, the onset of effects can take anywhere from 30 to 60 minutes. Some people use a method called lemon-tek to speed up this process. During this time, it’s normal to have anticipatory or anxious thoughts enter your mind – “am I really ready for this?” or “I wonder if it’s kicking in yet?”
Try to keep your focus on your breath and your intentions and not over-anticipate your experience at this point. Remember that this experience is safe, and do your best to let go as if you were drifting to sleep. By staying centered within your body and managing the tendency to overthink, you’ll be better able to surrender to the experience once the psilocybin takes effect.
Between hours 1.5-4.5 after taking the dose, you’ll be at the peak of the experience. The “come-up” can be accompanied by anxious thoughts and feelings of fear. This is completely normal. Remember to remind yourself that you are safe, you are taken care of, and to trust in letting go.
It’s helpful to have some “mantras” or anchors on hand that can help you accept what’s happening in the moment. Researchers at Johns Hopkins encourage study participants to repeat the anchor:
Trust. Let go. Be Open.

Other helpful anchors may include:
- I am safe
- I am open
- I am worthy of healing
- I welcome this experience
Repeating these messages to yourself in your mind can help you calm the fears and welcome whatever psilocybin is presenting to you during the session.
During this time, challenging psychological content may arise. You may feel that you’re losing control, or that the experience is too much, too fast. Difficult emotions, such as fear, grief, or sadness, may come up.
You may be taken back to specific memories or be confronted with uncomfortable truths about yourself and your life. You may have emotional breakthroughs and realizations. It’s also possible that you experience intense joy or ecstasy – psilocybin can bring on the full spectrum of emotions, and there’s no real way of knowing what will emerge during the session.
You may feel physical discomfort and sensations, including nausea or headache, or experience physical and emotional release, such as through shaking, crying, or laughing.
It’s important to remember that all of this is normal and part of the process of healing from anxiety. Healing isn’t always comfortable. Additionally, having a challenging experience doesn’t mean you had a bad trip. Even in therapeutic settings, challenging journeys are common and are associated with positive changes after the experience.
Here are some helpful tools to help you calm anxieties and ground during your psilocybin session:
- Invite gentle oscillation between difficult material and neutral anchors such as the breath, contact points, or sounds. For example, you might touch the difficult feeling for a few breaths, and then rest back in the breath or feeling a part of your body, and go back again. This reduces overwhelm without avoidance.
- Engage short cues that make room for sensations. For example, “Allow this wave,” or “Name it, breathe it, let it be.” ACT-informed models help enhance experiential acceptance and values-guided action during the integration process.
- Use slow, longer exhale breathing, soften your jaw and shoulders, and feel three points of contact (such as your heels, seat, and back). Find a comfortable posture and get whichever comforts help you relax, such as being covered by a blanket. Simple, body-based cues can down-regulate arousal and signal to the nervous system that you’re safe.
- Music is a central element to your journey. If it feels too intense or overstimulating, you can ask your guides to lower the volume, change the track, or pause for a brief silence.
- Trained facilitators provide reassurance and attend to your safety and comfort, without steering content. If you need support, ask for it from your facilitator – they are there to help you navigate the psilocybin experience.
Lastly, while making yourself comfortable to navigate the experience best is important, it’s equally important to recognize when you are seeking comforts as a crutch to avoid discomfort. Taking psilocybin for anxiety may naturally evoke discomfort, and you want to be careful that you don’t avoid the work that lies ahead of you by trying to escape the experience.
Pay attention to shifting a lot in your position, repeatedly thinking the music isn’t quite right, or thinking that everyone around you is too noisy – these are all examples of common defense mechanisms to avoid feeling difficult emotions.
The most therapeutic psilocybin experiences for anxiety will bridge this gap between feeling prepared and comfortable while allowing yourself to confront the difficulties that arise to heal. If this is challenging, lean on the support of your facilitators rather than trying to escape discomfort.
Accessing Your Inner Healing Intelligence
A helpful concept for psilocybin work – and one that is used frequently in clinical psychedelic-assisted therapy settings – is that of an inner healing intelligence.
This is the notion that we have a natural, innate ability to heal if we allow ourselves to trust and get out of our own way. Connecting with your inner healing intelligence during a psilocybin session can help you feel more empowered and develop a deeper sense of self-trust. However, it’s important to fully surrender to the experience for this process to unfold to the fullest extent. Using the tools we mentioned above and leaning on the support of those who are guiding you will help you let go and tap into this inner healing intelligence. Once your mind stops fearing, analyzing, or doubting the experience, psilocybin connects with this process to stimulate radical healing of trauma, which in turn reduces the symptoms of anxiety.
Therapists and facilitators who adopt this approach are non-directive and seek to help you connect with your own healing capacities. These psychedelic practitioners provide an environment where you feel safe enough to let go and offer guidance to help you best engage with the psilocybin session.
The Mystical Experience and Emotional Breakthrough: Why They Matter For Anxiety
During high-dose psilocybin experiences, many people report having a mystical experience. In clinical studies, this is defined as feeling a sense of unity or interconnectedness, sacredness, “felt truth”, transcendence of time/space, and deep positive mood.
According the Mystical Experience Questionnaire (MEQ30), a “complete mystical experience” is defined as a score of more than 60% of the maximum possible score for each of the MEQ30’s four subscales: mystical, positive mood, transcendence of time and space, and ineffability.
While no two are the same, they are a fairly common feature of high-dose psilocybin journeys. They are correlated with reductions in anxiety and depression post-experience, and related to persisting positive effects. The occurrence of a mystical experience with psilocybin can also greatly assist those with end-of-life distress.
Many study participants also report a wave of emotional catharsis during psilocybin journeys. As mentioned above, this can involve crying, shaking, and a felt sense of “letting go” of pent-up emotions or traumas. Emotional breakthroughs during psilocybin sessions help to increase psychological flexibility, which is known to lead to reduced depressive and anxious symptoms.
Following mystical experiences and emotional breakthroughs, people may feel more able to let go of rigid narratives (e.g., “I can’t cope” or “The world isn’t safe”), creating space for new, healthier beliefs about self and the world.
People often emerge more willing to contact difficult feelings and pursue values-based actions. This shift can help reduce anxiety after psilocybin, giving people a sense of, “I faced my inner demons, so now I can face anything.”
Having said that, a mystical-type experience or catharsis is not necessary to receive the benefits of psilocybin therapy. Many people experience huge improvements without them – the most decisive factors remain proper preparation, therapeutic support, and integration.
Integration: Weaving Your Experience Into Your Daily Life
Once your psilocybin journey has finished and you land back into your life, you enter into the integration period. This is when you integrate everything you experienced during the session into your day-to-day life.
Immediately following the journey, it’s important to give yourself time and space to ground again and start processing your experience. This looks like lots of rest, sleep, journaling, and nourishing meals and movement. It’s also common for information to continue coming through in this initial stage, so stay open to further insight and make space for this process to unfold.
During your session, you may have received insights on changes you wish to make – habits you’d like to leave behind, or new ones you want to implement. Part of integration is making these positive changes, especially during the window of neuroplasticity in the days and weeks following the session. When you’re in this window, integrating new habits and thought patterns can feel smoother, and they’re more likely to stick for the long term.
Integration also involves adopting new perspectives and ways of being in the world. This process can go deeper than a to-do list of new healthy practices – and often requires continued deep inner work to fully embody a new identity or state of being.
Journaling and nervous system work can be crucial here, as well as having the support of trained professionals. You might want to seek out integration therapy or coaching, or integration circles, where you can safely explore and unpack your experience in the presence of others on a similar path. Legitimate psychedelic practitioners and retreat centers will have some level of integration support built into their programs.

It’s not uncommon to experience challenges during the integration period. Psilocybin can bring up difficult psychological material, including past traumas and emotions that have been suppressed. You may even feel more mentally unstable or anxious following a psilocybin journey. This is normal and often part of the healing process – try to see it as an invitation to explore and process the emotional content that’s coming up.
Sometimes things have to get worse before they get better, but it’s vital you find support if this is the case for you. Remember the axiom “You have to feel it to heal it” – by being able to process these emotions in a safely-held container, you can begin to release yourself from their grip.
Specific therapies that can work well for those using psilocybin for anxiety include Acceptance & Commitment Therapy, Mindfulness-based Therapies, Cognitive Behavioral Therapy, and Internal Family Systems.
Choosing a Practitioner or Center for Psilocybin Work
If you are seeking out a guided psilocybin experience, we encourage you to thoroughly vet any practitioner or retreat center you’re considering working with.
Providing psychedelic experiences is a responsibility that cannot be overstated and should only be done by individuals who have undergone the necessary education and training. This is especially the case when holding space for people who have deeper mental health struggles and may need more specialized attention.
Make sure to do your due diligence by asking the practitioners or retreat centers:
- What is your background in training for psychedelic facilitation or psychotherapy?
- Do you have medical or psychotherapeutic professionals on your team?
- What experience do you have treating individuals with anxiety?
- How do you screen participants before accepting them?
- What preparation support do you provide?
- Who will be present during the session, and what is their role?
- What environment do you provide during the session?
- What is your approach if I become anxious or distressed during the session?
- What kind of integration support is included afterward?
- Is psilocybin legal in your location and under what framework?
You should also consider:
- What is the pricing of the retreat or journey, and is it within my budget?
- Where is the center located, and can I make arrangements to travel if it’s further away?
- What kind of setting do I want to be in – is it important to be in nature, or will a therapist’s office suffice?
- If the journey is being offered as an underground service, am I comfortable with that, and what risks does that imply?
Thoughtfully weighing up your options, using discernment, and tapping into your intuition will help you choose a practitioner or center where you feel safe and that caters to your unique needs.
For more insight into how psilocybin retreats at MycoMeditations could support you in overcoming anxiety, check out our testimonials page.
Psilocybin-Assisted Retreats: A Path Towards Anxiety Relief
Living with anxiety can feel overwhelming, but a growing body of research and anecdotal evidence indicate that psilocybin shows real promise in helping people move beyond cycles of fear and rumination.
However, psilocybin isn’t a magic pill or a quick fix. The most meaningful transformations come through careful preparation, guided support, and intentional integration afterward. For many, retreats provide the safe, structured environment needed to explore these experiences.
Psychedelic retreats like MycoMeditations provide access for people seeking gold standard therapeutic care utilizing psilocybin therapy, offering a framework that supports lasting improvements in anxiety that has been proven by data.
If you live with anxiety, know that you’re not alone. We invite you to explore how an expertly guided psilocybin retreat may offer you the hope and healing you’ve been seeking
The Importance of Dose for Psilocybin Therapy and How To Get it Right
No matter how finely you tune your mindset and the environment in which you take psychedelics, if the dose is too low, it can be difficult to have a breakthrough experience.
Clinical research has gone down the route of standardized doses for psilocybin therapy. Standardized dosing makes sense for research purposes, but it may also get in the way of maximizing therapeutic outcomes. At MycoMeditations, we see that personalized dosing is necessary to achieve the best results. There is no one-size-fits-all approach when it comes to how many grams to take for psilocybin therapy.
The dose for psilocybin therapy can make the difference between a transformative experience for a client and a mediocre outcome. Set and setting work in conjunction with a personalized psilocybin dose to determine the experience at a mushroom retreat. Clinical trials illustrate that set and setting can help patients get the most out of a standardized psilocybin dose. We take the lessons from these trials and personalize doses for retreat participants so that mental health benefits are maximized.
But getting a personalized psilocybin dose correct requires care and diligence. There are risks associated with dosing incorrectly, which may occur without proper client screening, training, or support available.
MycoMeditations dosing protocols are proven to be effective for psilocybin therapy. In this psilocybin therapy dosing guide, we will help you understand the factors that determine the right dose for clients seeking therapeutic psychedelic experiences.
The Standardized Dose for Psilocybin Therapy in Clinical Trials
Many psychedelic clinical trials have used a standardized therapeutic dose of 25 mg of synthetic psilocybin for the treatment of various mental health conditions. This equates to around 2.5 grams of dried Psilocybe cubensis mushrooms, based on the average potency of these psilocybin mushrooms. (25 mg can equate to up to 4 grams of less potent Psilocybe cubensis mushrooms.)
While 2.5 grams is generally considered a low to moderate dose, in clinical trials, researchers find it is sufficient to induce mystical experiences in percentage of the participants. As Sam Gandy writes, this “dosage appears to be a good compromise between maximizing the chances of a mystical experience, while minimizing potential for adverse reactions.” (In clinical trials, ‘adverse reactions’ can include anything from nausea to transient anxiety. In our protocols, these aren’t symptoms to shy away from but rather are challenging reactions that, if worked through, can lead to deeper states of healing.)
2.5–4 grams of Psilocybe cubensis mushrooms is on the lower end of the dosage range in our experience. While we understand why clinical researchers want to be on the conservative side, this doesn’t mean the standard dose of 25 mg is ideal for everyone. The results of clinical trials are positive, but trial participants represent a rare segment of people using psychedelics for mental health. They often have no comorbidities; they’ve been weaned off medications for long periods of time; and they undergo long periods of continual one-on-one therapy in the trials, which factors into the results.
We need to acknowledge the limitations of psilocybin dosing protocols in clinical research. Standardized psilocybin doses don’t allow room to optimize the dose for each individual. A personalized psilocybin dose can increase the efficacy of psilocybin therapy by taking all variables into consideration.
A growing body of evidence supports the effectiveness of psilocybin therapy. The Food and Drug Administration (FDA) has already granted two breakthrough therapy designations for psilocybin in the treatment of treatment-resistant depression (TRD) and major depressive disorder (MDD). If the FDA approves psilocybin therapy, it will include the approval of a standardized dose of psilocybin, along with a specific therapeutic approach and several psychotherapeutic support sessions. This means no variability or customization. For optimal psilocybin therapy, the dosing protocol should vary between individuals.

The Rationale for a Personalized Psilocybin Dose
Personalized dosing for psilocybin therapy takes into account all the factors that set someone up for the best possible psilocybin experience. (We will unpack these factors in a later section.) This doesn’t mean there is no value in standardized psilocybin therapy dosing, but this should be used more as an initial entry point, rather than something to rigidly stick to throughout subsequent dosing sessions.
In an initial psilocybin therapy session, a standardized dose can help us observe how a person responds to the effects of psilocybin. At MycoMeditations, we use a 3- or 4-gram dose of psilocybin mushrooms for all new guests. This is similar to the ‘high dose’ used in clinical trials.
In our experience of administering many thousands of psilocybin therapy sessions, this is a conservative dose that allows people to have a gentler experience to get familiar with altered states. However, this dose doesn’t typically push anyone truly into the psychological material they have ultimately come to us to process and heal from. There is a chance that this small dose induces a mystical experience, but the likelihood of a mystical experience is significantly higher with a larger dose.
A trained psychedelic facilitator can then see how the person reacts, and based on that, a future dose for psilocybin therapy sessions can be modified. You can see a variety of responses to a standardized dose. Visual effects are common (although they vary in intensity between individuals). Some people get insights (which also vary in their importance and lasting impact). However, 3–4 grams of dried psilocybin mushrooms is rarely the optimal dose. Once people gain familiarity from that initial experience, they are often ready for a higher dose for deeper therapeutic effects.
Why Use a Higher Dose for Psilocybin Therapy?
At MycoMeditations, we find that a personalized dose for psilocybin therapy to ensure significant and durable outcomes for depression, generalized anxiety, social anxiety, PTSD, and more often requires going into high-dose terrain. There are several reasons why high doses of psilocybin can encourage therapeutic experiences.
Increased Disruption of the Default Mode Network
The default mode network (DMN) is a network of brain regions that is most active during wakeful rest, such as during daydreaming and mind-wandering. Its overactivity is linked to conditions like depression. The weakening of its activity, when one is under the influence of psychedelics, is associated with mystical experiences and mental health benefits. High psilocybin doses are more likely to have powerful effects on the brain, including a weakening of the DMN, offering relief from negative, ruminative thinking.
Higher Probability of a Mystical Experience
Psychedelic mystical experiences – featuring self-transcendence, unity, profound insight, sacredness, and ineffability – are more strongly correlated with therapeutic benefits. They are not the only predictor of benefits: insights, emotional breakthroughs, and alterations to one’s sense of self matter, too. But we can’t discount the importance of spiritual experiences. For example, they’ve been associated with reduced fear of death and improved well-being.
Overcoming Psychological Resistance and Mental Barriers
With psychological support present, a higher psilocybin dose can help a client overcome unconscious barriers. When someone desperately wants to heal on a conscious level, they can still encounter psychological resistance during a psilocybin experience to avoid feeling uncomfortable emotions, which prevents them from fully letting go.
Low to moderate doses of psilocybin leave the ego structure (ie. their beliefs, identity, psychological patterns) largely intact, allowing them to maintain some level of control over the experience. A high psilocybin dose, in contrast, makes it natural to let go of control and surrender to the experience due to the disruption of DMN, which is essentially the ego structure previously described. This process allows unconscious psychological material to emerge into awareness for fuller processing.
We never push people to accept a high dose of psilocybin if they’re not ready for it. However, we recognize that when someone is adequately prepared and supported, a high dose can help overcome aspects of ourselves that are based on fear and excessive need for control.
While large doses of psychedelics can be associated with distressing experiences in uncontrolled contexts, low-moderate doses can also lead to difficulties. Small doses can make it more likely that someone will resist the unfolding effects distressingly, when there is a potential for a personal breakthrough on the other side. When a high-dose psilocybin experience is supported, it is easier for someone to feel safe, trust the experience, and surrender to it, which researchers find predicts positive, therapeutic experiences.
Larger doses can break through layers of resistance, where the mind is freer to process trauma and deep wounds without the rational, analytical mind standing in the way. Accessing this kind of experience leads to outcomes that are otherwise inaccessible with lower doses. The key to taking the right amount of mushrooms, or a personalized psilocybin dose, is working with a trained, trauma-informed facilitator. These types of experiences can be deeply cathartic, so they require specialized, direct care. With the proper support present, a 5+ gram dose for psilocybin therapy is entirely safe and often the optimal path for best outcomes.

Factors That Determine the Right Dose for Psilocybin Therapy
Deciding on a personalized psilocybin dose should take into account several factors, including:
Mental Health History
Generally, treatment-resistant depression and treatment-resistant anxiety require higher doses. Depression is shown to cause severe emotional blunting, which makes it challenging to process emotion within psilocybin therapy. Anxiety involves a mind that is in a constant state of hypervigilance, which can disrupt the unfolding psychedelic experience. More strongly muting the DMN can overcome these barriers, allowing one to access deeper emotional states.
History of Psychedelic Use
If someone has never used psychedelics before, then it could make sense to stick with a lower, standardized dose of psilocybin to mitigate the chances of overwhelm and distress. On the other hand, if someone attends a psilocybin therapy retreat with many experiences under their belt, including high-dose ones, then they would be more prepared to take a higher dose.
Willingness for Intensity
High doses are only appropriate if the client feels safe taking them and is willing to do so. Even when a mental health condition could benefit from a 5+ g dose of mushrooms, the client’s own readiness to face difficult material is the main factor that determines the correct dose for psilocybin therapy at that time.
Pre-existing Nerves
Some clients are so nervous and anxious before a dosing session that a large dose would not be wise, and can even be harmful. This is because psychedelics can magnify our inner state and emotions. Even if a high dose of psilocybin would benefit someone at some point in the future, if they’re excessively nervous, a lower dose is necessary to ensure they have a safe and comfortable experience.
Comfort with Psychedelics
Clients need to be able to trust the medicine they use. Lower doses allow clients to see how psilocybin affects them, making it easier to establish a personalized psilocybin dose for the next dosing session.
Quality of Previous Experiences
An initial standardized psilocybin dose helps facilitators gauge how open or resistant someone is during the experience, how intense it already is, the depth of the experience, how easily they retain insights from it, the emotional depth that is accessed, and their ability to make sense of it all. All of these factors enable facilitators to determine the ideal dose of psilocybin for each client.
Tolerance Buildup
When dosing sessions are close together, tolerance is a factor. At MycoMeditations, we administer doses 48 hours apart and have found that the optimal psilocybin dose must account for a 10–20% increase. For example, dosing 6 grams one day and aiming for a similar intensity 48 hours later would mean 7 grams is likely ideal.

Finding the Right Dose is a Careful Balancing Act
It can be challenging to find the right amount of mushrooms to take during a psilocybin retreat.
Too low a dose may prevent someone from accessing the kinds of altered states where their analytical mind, resulting from the Default Mode Network, goes offline. Dosing too high can cause people to get into a state of panic, where they fight the experience, which may lead to a prolonged state of distress.
Psilocybin retreat facilitators must work with clients at their current mental state and level of readiness. This personalized approach to psilocybin therapy dosing is the best way to establish the right amount of mushrooms to take.
Misconceptions About Psilocybin Dosing
We also want to clarify some misconceptions about determining the right dose for psilocybin therapy.
First, doubling a dose does not mean doubling the intensity. Each dosing session is unique. If anything, many guests at MycoMeditations retreats report that higher doses offer a ‘smoother’ experience. This is because their analytical mind is offline, and they feel more present with the fullness of the experience. Often, it’s the resistance, fighting, and grappling with fear that are the most difficult parts of a psilocybin experience.
In line with the ‘inner healing intelligence’ described in MAPS’ protocol for MDMA- and psychedelic-assisted therapy, if we can ‘get out of our own way’, the deepest kinds of healing experiences become possible through our own natural inner faculties.
A second misconception about personalizing psilocybin dosing is that doses should be adjusted based on weight. As Spriggs et al. note, there is a lack of evidence showing that bodyweight is a predictor of subjective experience to psilocybin.
Final Thoughts on Psilocybin Dosing Protocols
The factors outlined above are the most significant variables in determining the ideal dose for clients undergoing psilocybin therapy. These insights have come from over a decade of experience hosting psychedelic retreats and administering thousands of legal psilocybin therapy sessions to our guests.
At MycoMeditations, our psilocybin dosing protocol takes into account tried-and-tested factors to ensure that each client receives a psilocybin dose that maximizes their potential outcome. We consider the extensive list of aspects that consist of ‘set’, so that we strike a balance between the client’s level of preparedness and the amount of mushrooms that can elicit profound experiences and lasting benefits. This could mean 4 grams for one retreat guest and 8 grams for another guest.
This overcomes the limitations of psilocybin dosing protocols seen in clinical research and shares MycoMeditations’ unique and proven dosing protocol, providing personalization and precision in our psychedelic retreat’s approach to psilocybin therapy.
Music and Psychedelics: Past, Present, and Future
The convergence of music and psychedelics is not just a modern phenomenon arising from the rise of therapeutic psychedelic use. This harmonious marriage is an ancient spiritual practice deeply rooted in human history, one that helps explain why the presence of music in psychedelic therapy is so significant.
Music has a significant impact on the human psyche. For millennia, humans have used sound to induce altered states of consciousness and ecstatic experiences. In the earliest human tribes, early forms of music served a role in uniting communities and connecting with the spirit world.
Sound-induced trance states allowed our ancestors to alter their consciousness and transcend the physical world into a mystical experience, from which they returned with meaningful symbols that formed the basis of our future metaphysical beliefs.
In the same way that our ancestors used sound to induce these ecstatic, spiritual states, they also consumed psychoactive plants and fungi for the same purpose, often combining the two for a deeper connection to the divine.
Today, as the field of psychedelic therapy grows, music’s ability to facilitate altered experiences has gained renewed attention. Featuring certain music in psychedelic therapy can help deepen someone’s emotional and mystical states, which is linked to therapeutic benefits.
The mechanism that gave our ancestors healing and connection to the mystical is integral to the emergence of psychedelic therapy. From indigenous shamanic ceremonies to modern clinical settings, music amplifies the therapeutic potential of psychedelics in profound and mysterious ways.
We examine the history, science, and future of music as they relate to the psychedelic experience, offering insights into why it plays such a crucial role and how it can be effectively curated to maximize the impact of psychedelic therapy. Indeed, we now have research on the best music for psychedelic therapy—the kind of music that increases the chances someone will have a profound, transformative therapeutic experience.
The Importance of Music in Psychedelic Therapy: A Historical and Cultural Perspective
In many ancient and shamanic traditions, sound is seen as a bridge between the physical and spiritual realms, guiding participants through transformative experiences and fostering a deeper connection to themselves, the universe, and the divine. The role of sound in these traditions helps to highlight the importance of music in psychedelic therapy:
- Shipibo Tradition (Peru): Music is an essential element of the Shipibo people within the Amazon rainforest, who work with ayahuasca in local ceremonies. Icaros, sacred songs believed to hold spiritual power, are at the core of their ceremonies. Icaros serve as navigational tools that guide the shamans through the complex spiritual landscapes opened up by ayahuasca. Each icaro is chosen for the needs of the ceremony, whether it is for protection, healing, or amplifying the effects of the medicine. The Shipibo healers, also known as curanderos or curanderas, receive these songs through their spiritual visions or from the plant spirits themselves, further emphasizing the sacred connection between music and psychedelics.
- Bwiti Tradition (Africa): In the Bwiti religion of Central Africa, music plays a central role in iboga ceremonies. Ibogaine, a powerful psychedelic derived from the root bark of the Tabernanthe iboga plant, is used as a sacrament to induce deep introspection and spiritual awakening. During these ceremonies, repetitive rhythms, drumming, and chanting create a hypnotic soundscape that helps participants enter and sustain altered states of consciousness. Psychedelics and music synergize, enhancing the experiences of participants in the ceremonies.
- Huichol Tradition (Mexico): The Huichol people, native to Mexico, incorporate music into their peyote ceremonies, where this psychoactive cactus allows access to spiritual insight and healing. The ceremonies are accompanied by the melodic sounds of traditional instruments, including violins, drums, and rattles, as well as chanting and singing.
- Siberian Shamanism (Russia and Mongolia): In the Siberian and Mongolian shamanic traditions, music plays a crucial role in ceremonies that involve the use of psychoactive plants or other trance-inducing practices. Shamans use instruments like drums, jaw harps, and throat singing to create rhythmic vibrations that help them and their participants enter altered states.
- Modern Psychedelic Therapy: The wisdom of shamanic traditions is translated in a modern context, in which we see the inclusion of music in psychedelic therapy. Playlists curated for therapeutic sessions often feature ambient, meditative, or classical music that complements the participant’s emotional and psychological journey. These are widely considered some of the best types of music for psychedelic therapy. Research has shown that music enhances the therapeutic effects of psychedelics by evoking deep emotions, guiding the experience, and helping participants process their insights. Each track is carefully selected. The best music for psychedelic therapy matches the different phases of the journey, from the initial ascent to the peak and eventual return to baseline.
Across cultures and traditions, the relationship between music and psychedelics serves a purpose. Music becomes a guide, a protector, and a tool for healing and connection through the amplification of emotional and spiritual intensity. Whether it’s through ancient rituals or modern therapeutic practices, this timeless connection underscores the universal power of music and sound to tap into the depths of human consciousness. This is why researchers have started to explore more deeply the role of music in psychedelic therapy, as we’ll see below.
The Synergy Between Psychedelic Therapy and Music
Psychedelics alter our perception of reality by dissolving the ego’s boundaries and beliefs, which serve to help us understand ourselves and everything around us in ordinary states of consciousness. They do so by disrupting the usual patterns between brain networks and enabling new connections, echoing research that shows how music has a similar effect of engaging diverse networks of brain regions. Combining psychedelics and music, therefore, can have a unique effect.
Music serves as an additional catalyst by guiding the unfolding psychedelic experience. The qualities of the selected music in psychedelic therapy help shape the perception and emotion of the journeyer. Together, psychedelics and music form a synergistic relationship, amplifying the potential for personal transformation and introspection.

Enhanced Emotions
Modern research supports the idea that music amplifies the therapeutic effects of psychedelics. Since psychedelics act on serotonin receptors, there is an enhancement of emotional and sensory experiences. When combined with music, these effects are significantly enhanced.
Emotional Catharsis
Processing trauma often necessitates accessing difficult emotions buried beneath layers of defence mechanisms, and music creates a safe container within which to explore those emotions. For example, in psilocybin therapy, calming tones may evoke nostalgia and safety, while heavier, dramatic pieces can help patients confront grief, loss, or fear.
Profound Visionary Experiences
Inner visions often accompany psychedelics, and the music playing during the experience can significantly influence the nature of these visions. Visions can serve as powerful tools for self-reflection, insight, and emotional release, making music a helpful means for individuals to connect with their inner world.
A Sense of Direction
Music also serves as a guide during a psychedelic experience by shaping the journey and providing direction. The qualities of the music create a trajectory that influences the emotional and mental path of the experience. By setting the pace and atmosphere, music helps navigate the depths of the mind, offering a sense of structure and flow as the medicine takes effect.
Mystical Experiences
Music can also help facilitate mystical effects. One study found that the best music for psychedelic therapy, to encourage a mystical experience, is overtone-based music. This is music featuring instruments with a strong overtone signature, such as Tibetan singing bowls, gongs, didgeridoo, chimes, bells, sitar, and human voice overtone singing. Participants in psychedelic therapy listening to this type of music were more likely to have a mystical experience than those listening to Western classical music.
A 2017 survey examined individuals who had experience administering psilocybin in a therapeutic context. The researchers wanted to identify the music that would best predict the occurrence of mystical experiences. They found that the best music for psychedelics, in this respect, was music with “regular, predictable, formulaic phrase structure, and orchestration, a feeling of continuous movement and forward motion that slowly builds over time”.
An example of modern music that has helped to support peak experiences is the track ‘Azure’ by Greg Haines. It features in Mendel Kaelen’s playlist used in Imperial College London’s 2016 study on psilocybin for depression. It occurs around the ‘peak’ timeframe of the psychedelic session (02:34:41). ‘Azure’ was one of the only songs that patients specifically mentioned in post-session interviews, due to the effect it had on them.
Music in Psychedelic Therapy’s Renaissance
The importance of music in psychedelic therapy cannot be overstated. With the resurgence of psychedelic therapy to treat depression, PTSD, end-of-life distress, and more, music has emerged as an essential accompaniment for this process. Clinical studies at Imperial College London demonstrate that curated music enhances the outcomes of psychedelic-assisted therapies. It serves as both a grounding element and an amplifier of experience, helping individuals navigate the complex nature of the psychedelic state.
But why is music’s role so crucial in the modern context?
- Guiding the Experience: Music in psychedelic therapy serves as a therapeutic guide, helping clients navigate various phases of their psychedelic sessions. For instance, uplifting tracks might support a “breakthrough” moment, while softer music during the descent phase fosters emotional integration.
- Connecting Therapists and Clients: Astute therapists can gain a deeper understanding of a client’s state by knowing the path taken by the music in psychedelic therapy. Shifts in emotional state often correlate with distinct phases of an album or playlist.
- Filling Emotional Voids: Psychedelic experiences can feel confusing or disorienting when left suspended without direction. Music fills this potential void, essentially acting as a co-therapist to help maintain emotional flow and stability.
Without this carefully curated soundscape, psychedelic therapy sessions lose an essential dimension that is shown to facilitate depth, safety, and meaning.
Research suggests that music takes on an entirely different quality during psychedelic-assisted therapy when compared to its properties in everyday circumstances.
When combined with the mind-altering effects of psychedelics, music is so profound that its presence is like a sentient actor that collaborates with the participants and therapists involved in the experience.
As we have seen, music can facilitate emotional catharsis, insights, and mystical experiences, which studies have found to predict therapeutic benefits. The best music for psychedelic therapy, then, is the kind that allows one to sink into a deep, internal experience.
What About the Role of Silence in Psychedelic Therapy?
The benefits of music in psychedelic therapy don’t mean that silence has no role to play in this form of treatment. One study looked at psilocybin-assisted therapy that incorporated intentional periods without music. It examined the experiences of two breast cancer patients receiving psilocybin therapy as part of Canada’s special access program. The authors write:
“Patients had previously experienced psychedelics in therapeutic contexts but only with continuous music, as is common practice. Here, each patient participated in a 30-minute silent period involving mindfulness exercises and therapist discussions. These periods of relative silence resulted in both challenges and benefits. One patient found that the absence of music was difficult initially, but that the relative silence allowed for engagement with mindfulness exercises that were experienced as highly meaningful. The other patient reported that music had evoked challenging past memories early in the dosing session, which were then productively explored with her guides during the subsequent period without music. These findings suggest that integrating silent intervals in psilocybin-assisted therapy can enhance mindfulness practices and therapist-patient interactions, potentially offering distinct therapeutic benefits.”

How to Prepare the Best Music for Psychedelic Therapy
Given how subjective the experience of music is, it can be a challenge to choose the best music for psychedelic therapy, as opinions differ from person to person. Whether you are creating a playlist for yourself or your clients, it requires an understanding of the participant’s emotional state, preferences, and areas of resistance, such as fear of losing control, confronting emotions, or over-analyzing.
Music selected in psychedelic therapy tends to evoke emotional experiences, and this process can be challenging to go through. Clients can often exhibit psychological resistances as a means to avoid change. These psychological patterns can be understood through adequate screening and preparation with clients, where psychedelic therapists can learn the client’s tendencies to support them best.
A successful music selection for psychedelic therapy will evoke feelings of safety, introspection, and openness, allowing the participant to access deeper layers of emotion and insight. The playlist should also align with the session’s goal. Selecting the wrong music can disrupt this process, cause confusion, and lead to distraction or detachment.
Selecting the right music requires intention and understanding of how it interacts with the unique states of consciousness induced during psychedelic therapy. A thoughtfully curated playlist or album design creates an ideal inner space for the individual to surrender to the process, be open to emotions, and achieve meaningful breakthroughs.
Key Considerations When Curating Music in Psychedelic Therapy
Theme and Resonance
Choose music that aligns with the participant’s preferences to create a more personalized and meaningful experience. For instance, some people might find classical compositions, such as symphonies or operas, too dramatic or opulent to relate to. On the other hand, others may resonate deeply with the complexities of classical music, finding it inspiring or cathartic.
Similarly, including tracks with yogic chanting may be well-suited for those looking to imbue their experience with an air of Eastern mysticism, or perhaps to connect them with an Indian lineage. However, others may find these songs too exotic and distant.
Understanding the participant’s unique tastes and what resonates with them is key to selecting music that enhances the experience rather than detracts from it.
Tone and Direction
Since music can significantly influence mood, identifying the purpose of the session is crucial in selecting the right psychedelic playlist to support the process. It is best to choose music with a particular emotional direction to set the overall tone and feel for the journey.
For example, a light, ambient tone with soft melodies might foster introspection, creating a calm and reflective atmosphere ideal for contemplation or moments of gentle emotional release. On the other hand, intense drum rhythms or dynamic, powerful compositions could evoke catharsis, helping to release pent-up emotions or trauma more actively and expressively.
Consider the tempo, tone, and emotional suitability of the music to ensure it complements the intended focus and desired outcome of the session, as this will guide you toward a deeper, more meaningful experience.
Timing and Transition
Music in psychedelic therapy should match the session’s arc, as this plays a crucial role in supporting the participant’s experience. Psychedelic sessions often follow a natural progression of ascent, peak, and descent based on each medicine’s unique duration period. The playlist for psychedelic therapy should align with these phases to create a cohesive and fluid journey.
During the ascent, the music can gently build anticipation and set a tone of curiosity and openness, preparing the participant for what lies ahead. At its peak, the music may be immersive and expansive, encouraging introspection, emotional release, or profound insights. As the session transitions to the descent, the soundtrack can gradually soften, offering a sense of grounding, comfort, and closure.
Another consideration is how individual songs are blended with those that precede or follow them. Psychedelic playlists that don’t mix well can be distracting. For example, if a song that predominantly features a cello is followed by a song with Tibetan throat singing, these songs will clash stylistically. This disharmony can be enough to disrupt the participant’s flow.
Ensure that transitions between genres or other musical qualities in the psychedelic therapy playlist are tasteful and gradual. Abrupt shifts in theme, tone, and style can disrupt the therapeutic process by pulling participants out of their journey.
Lyrics
Music with lyrics in the participant’s native language is generally avoided in psychedelic therapy because it can be overly directive, potentially influencing thought patterns or emotions in a way that distracts from the participant’s own organic experience. Research even shows that lyrical music interferes with cognitive tasks.
Instead, non-lyrical music is often preferred in psychedelic therapy. Vocals in a foreign language can also work, as the participant won’t be able to focus on the meaning of the lyrics. These styles provide a sense of humanity and connection without dictating or interfering with the participant’s process.
As you can see, compiling music playlists for psychedelic therapy is an art that involves psychological, emotional, and artistic considerations to support the best therapeutic process.
Ultimately, thoughtfully curated music in psychedelic therapy acts as a guide. It enhances the therapeutic potential of the session by helping participants navigate their internal landscape with greater ease and depth. By setting the tone and holding space for all that emerges from within the participant, the music provides a foundation for the therapeutic process while remaining unobtrusive and supportive. Music’s role is to enhance, not overshadow, the journey by ensuring that the internal experience remains the focal point. This careful balance between guidance and neutrality is what makes music such a powerful yet delicate tool in therapeutic contexts.
Key Artists Making Music for Psychedelic Journeys
Innovative artists are helping to highlight the profound potential of music in psychedelic therapy, recognizing its powerful ability to enhance emotional processing and create deeply immersive experiences.
Wavepaths, founded by Mendel Kaelen, an early psychedelic researcher at Imperial College London, offers personalized, AI-curated soundscapes for psychedelic sessions. They create adaptive musical environments to support the dynamic and unique nature of psychedelic experiences through their platform. Based on all the factors discussed above, artificial intelligence, as used by companies such as Wavepaths, can enable us to tailor psychedelic therapy music selections to the exact needs of each client.
Several artists have also pursued the creation of music for psychedelic journeys. They include Jon Hopkins, East Forest, and Justin Boreta. Given the growing list of artists who have shared about how psychedelics positively impacted them, it’s easy to see why attention is going towards the musical component of therapeutic psychedelic experiences.
A quick search on Spotify or Apple Music for “Psychedelic Therapy” playlists will show curated lists consisting of additional artists ranging from Antonio Vivaldi to Brian Eno, Enya, Max Richter, and many more.
These artists, old and new, all highlight the modern intersection between music and psychedelic therapy. Their musical innovations demonstrate how we can harness sound to best support the unfolding process of a therapeutic psychedelic journey.
Best Playlists and Albums for Psychedelic Therapy
Music is an essential part of our psilocybin therapy sessions. Based on what this article has outlined, the “best” choice for any individual is impossible to determine due to how multifaceted the experience of both psychedelics and music is. However, it is possible to make a choice that is close to ideal.
We have compiled our top playlists for psychedelic therapy to help you narrow your selections for any upcoming psychedelic sessions you are preparing for.
Music for Psilocybin-Assisted Therapy
Designed by Bill Richards for the psilocybin-assisted therapy research done at Johns Hopkins University.
Created by Mendel Kaelen for psilocybin therapy studies at Imperial College London.
Made for psilocybin research at Copenhagen University Hospital. Its curation is highlighted in this in-depth analysis.
This album, created by East Forest, was inspired by his experiences at Mexican mushroom ceremony.
East Forest’s second album with his signature sound and style for psychedelic therapy.
This album is a research-backed creation for psychedelic therapy from Massey, New Zealand, consisting of a live recording utilizing 28 musicians.
Curated by MycoMeditations. Ambient music with a unique variety of tones, vibrations, and brain frequencies to deepen the therapeutic experience.
Curated by MycoMeditations. Shamanic, primordial themes with highly energetic elements that heighten and expand altered states of consciousness.
Curated by MycoMeditations. Gentle progression into a powerful mix of ambient, shamanic, and instrumental music for the peak experience.
Music for Ketamine-Assisted Therapy
Music for MDMA-Assisted Therapy
Final Thoughts: Music in Psychedelic Healing
Psychedelic therapy is ushering in a new era for mental health, and music is an indispensable part of this movement. It harnesses age-old traditions, amplifies modern scientific findings, and connects clients to their therapists, emotions, and themselves.
Looking ahead, there’s potential for even more innovation in music for psychedelic therapy. AI-driven soundscapes, immersive experiences, and personalized soundtracks will continue to shape the field in the years to come, leveraging music’s ability to facilitate profound healing.
Are you exploring new mental health solutions or seeking personal transformation with psilocybin therapy? As the original therapeutic psychedelic retreat, MycoMeditations provides the perfect setting for safe, expert-guided psilocybin therapy sessions alongside our carefully selected list of music playlists and albums for an unparalleled experience.
Ayahuasca vs. Psilocybin: Which is Right for You?
Not all psychedelic substances are the same. Choosing between the potential benefits of substances like ayahuasca or psilocybin mushrooms is more than a matter of chemistry, as each is used in different contexts.
The use of ayahuasca and psilocybin mushrooms (or magic mushrooms) goes back thousands of years. However, modern use cases for psilocybin mushrooms and ayahuasca are being integrated into a society hungry for solutions to dismal mental health conditions and what some call a “crisis of meaning.”
Psychedelic retreats using ayahuasca and mushrooms may incorporate practices established by indigenous peoples to navigate these unique experiences. However, the exploding interest in psychedelics from advances in scientific understanding and a modern therapeutic emphasis are changing the use of these medicines in contemporary societies.
In this article, we explore the difference between ayahuasca and psilocybin mushrooms. From ancient use to modern evolution, chemical compounds, physical and mental effects, and what to expect at ayahuasca and mushroom retreats.
Ayahuasca vs. Mushrooms: How to Choose the Right Healing Experience
Before booking an ayahuasca or mushroom retreat, it is important to examine the type of environment you want to have your psychedelic experience in, as well as your needs and intentions. With the large variety of backgrounds and approaches from providers across numerous countries offering psychedelic retreats, it is essential to select a retreat that most closely resonates with you and your goals.
Different ayahuasca and psilocybin retreats will have unique frameworks for relating to the medicine experiences and providing integration. Based on this framework, the staff will support you in a way that aligns with their process, and the retreat will attract people who resonate with this approach to the medicine.
- Are you looking for a therapeutic retreat that incorporates elements of psychotherapy with which you are most familiar?
- Do you want to experience ayahuasca or psilocybin mushrooms authentically through another culture with the help of a shaman?
- Are you interested in exploring consciousness and spirituality?
- Are you hoping to heal trauma and overcome mental illness?
It’s essential to ask these questions, as they will help guide you to an ayahuasca or mushroom retreat provider that is best equipped to offer the support that aligns with your goals.
Setting Intentions for Ayahuasca and Psilocybin Experiences
“Setting an intention” is a popular phrase in psychedelic circles. It means asking “Why do I want to do this?” Some people may be seeking healing. Others, personal development. For another, it may be spiritual exploration. There are countless reasons to seek out a psychedelic experience, each highly individual.
An intention is typically a simple and personally meaningful statement that helps people navigate and make meaning from psychedelic experiences. Intentions could be statements like “I will stay curious,” requests like “Help me find ease,” or questions like “Why am I here?”
Understanding why you will spend time, money, and a great deal of energy on what many claim to rank as one of the most significant experiences of their lives is essential. Intentions matter because they guide you to the right retreat centers, therapists, facilitators, and groups of people with whom you will share the experience.
Once you know your motivations, the next step is to find the right retreat. Here are some questions to consider before embarking on an ayahuasca or psilocybin journey:
- Why am I doing this?
- What am I hoping to accomplish?
- Where will I be the most comfortable?
- Who do I want to be around?
- What modalities will the facilitators be using?
- What kind of support do I want?
- What is the ratio of guests to facilitators?
- What substances are best for me?
- Which protocols are in place?
- How does integration with this group work?
With an understanding of why you want to join a psychedelic retreat, it is easier to choose between ayahuasca and mushrooms. Specifically, there are some differences between:
- Active components of each substance
- The context they are taken in
- What the psychedelic experience is like
What are Psilocybin Mushrooms?
Psilocybin mushrooms are naturally occurring fungi growing worldwide and have a rich historical use. Mushrooms appear in the rock art found at ancient sites. References to mushroom use appear on most of the world’s continents. We know the Aztec and Maya people of Central America used mushrooms, calling them the “flesh of the gods.”
When Spanish colonists suppressed the use of mushrooms, the practice continued in secret until 1955, when a Mazatec curandera, Maria Sabina, shared mushrooms with an American banker, R. Gordon Wasson. These “magic mushrooms” soon became a cultural sensation, leading to the discovery of new psilocybin species and their introduction into the Western world through scientific research and the 1960s counterculture movement.
After decades of prohibition starting in the early 1970s, psilocybin mushrooms have returned to the spotlight of clinical research and at psilocybin therapy retreats. Now, scientists and therapists have found newfound curiosity for the psychological impacts and psychedelic effects of the psychoactive compound “psilocybin.”

What is Psilocybin?
Psilocybin is one of many active compounds found in psychedelic mushrooms and appears to occur only in fungi. The most common is Psilocybe cubensis, but we know of approximately 180 species within the category of “magic mushrooms”.
Scientists are still learning how psychedelics work. So far, we know that when psilocybin is consumed, it is converted into the active psychoactive compound, psilocin. Psilocin is what interacts with receptors in our nervous system and is responsible for the psychedelic effects of psilocybin mushrooms, as psilocybin itself is not bioactive. Different receptor sites are associated with various functions in the body. Psilocybin interacts with multiple receptors, but special attention is focused on the 5-HT2A receptor. The 5-HT2A receptor appears to be the key receptor with which all classic psychedelics interact, creating consciousness-altering effects.
What is Ayahuasca?
No one can confidently say how long ayahuasca has been in use. The origins of ayahuasca consumption can be traced back to the indigenous people of the Amazon rainforest in South America, notably the Shipibo-Conibo. People practicing ayahuasca traditions with minimal interference from the outside world have kept the relationship between ayahuasca and “vegetalismo”, or learning from plants and spirits, strong. These traditions, now commonly called “shamanism,” are a big part of ayahuasca ceremonies.
The worldview and traditional medicine of the Amazonian people is a complex world of relationships that a shaman navigates to facilitate healing. The culture surrounding the ayahuasca experience remains somewhat mysterious to outsiders, but its reputation has inspired researchers to study the psychedelic brew.
Ayahuasca is a mixture of several different plants. The core of this mixture consists of the ayahuasca vine (Banisteriopsis caapi) and the chacruna plant (Psychotria viridis). Combining these plants and drinking the mixture allows for the compound N, N-dimethyltryptamine (DMT), the primary active alkaloid responsible for the ayahuasca experience, to induce its signature altered state.

What is DMT?
DMT is a naturally occurring compound found throughout the natural world. It is produced in the human body and many plants. Usually, DMT inside the human body is broken down rapidly, making psychedelic effects short if smoked in its pure form or nonexistent if eaten. DMT is broken down by an enzyme in the body called monoamine oxidase.
People in the Amazon figured out that ingesting the ayahuasca vine prevents the breakdown of DMT because it contains other active compounds known as “monoamine oxidase inhibitors.” Researcher Dennis McKenna documented how the Banisteriopsis caapi vine “inhibits” the activity of MAO, allowing DMT to be consumed in an orally active form.
DMT’s molecular structure is very similar to psilocybin, and both interact with the body in comparable ways. Each compound binds to similar receptors but elicits different reactions, along with interacting with multiple groups of receptors. Despite similarities between their physical and mental effects, there are some differences between the two substances.
Ayahuasca vs. Psilocybin Mushroom Experiences: What’s the Difference?
While both ayahuasca and psilocybin mushrooms generally share positive outcomes when taken responsibly, the journey that ayahuasca or mushrooms take people on to arrive at their goal is different. As they say, it’s not the destination but the journey. The actual experience of each substance will depend on the dose, preparation, and “set and setting.”
Set and setting are linked to achieving desired results with psychedelics and are key differences in the ayahuasca vs. mushrooms conversation.
“Set” means the mindset one has going into a trip. Mindset includes:
- Expectations
- Intentions
- Beliefs
- Personality
- Emotional landscape
- Knowledge and research
- Framework of understanding
“Setting” refers to the environment in which an experience occurs. Considerations here are:
- Comfort
- Safety
- Legality
- Other participants
- Facilitators
- Culture
- Music
- Inside vs. outside
- Objects present
Researchers, therapists, and group facilitators spend a great deal of time creating the ideal setting and mindset for ayahuasca and psilocybin experiences, as they both feed into one another. The emphasis on these concepts is strong because data shows clear connections to optimal set and setting leading to improved outcomes.
In 2025, a guideline called Reporting of Setting in Psychedelic Clinical Trials (ReSPCT) was developed through a consensus study that involved interviews with 89 experts involved in psychedelic research. The ReSPECT guideline outlines the 30 most critical set and setting variables for psychedelics practitioners and researchers to consider when working with clients or study participants.
The most apparent distinction between ayahuasca and mushrooms is not just their effects, but the context in which they are consumed.
Effects of Ayahuasca and Mushrooms
Both ayahuasca and psilocybin are classical psychedelics. They are comparable because they induce altered states involving:
- Visual distortions
- Visions and memory activation
- Amplified feelings and emotions
- Cognitive insights and introspection
- Dissolution of the ego
- Changes to heart rate and body temperature
- Physical reactions such as nausea, sweating, shaking, or yawning
The compounds also show groundbreaking potential in the laboratory as a much-needed mental health treatment. Psilocybin has progressed to clinical trials and is designated a “breakthrough therapy” by the FDA, paving the way for widespread legal access.
On average, both ayahuasca and psilocybin experiences last for about 4-6 hours. Both substances may help people with a growing list of other tough-to-treat conditions, including:
Ayahuasca and psilocybin mushrooms both require screening for mental and physical health concerns. Reputable psychedelic retreats offering ayahuasca and mushrooms will have a detailed application process and firm knowledge of what is and isn’t safe. Asking questions of retreat organizers should be easy, and the answers should be clear.
Ayahuasca – What to Expect
Ayahuasca is often held in a group ceremonial setting. An ayahuasca ceremony is typically led by traditional healers who have undergone extensive training in the jungle as part of an apprenticeship that includes learning directly from the plants and spirits. Shamans work with a unique set of tools that have been passed down through generations of curanderos and curanderas within their lineage.
The shaman often speaks very little and instead sings icaros, which are healing songs said to be delivered by the spirits of the plants. Relationships with various plants, animals, and spirits may also be part of the healing work, and to navigate these, shamans will sing, pray, and work with other healing plants, such as tobacco.
Ayahuasca traditions often focus on “cleansing”, and a powerful function of the ayahuasca brew is “la purga” or “the purge.” This manifests as strong physical effects, such as vomiting, diarrhea, crying, or shaking. From the Amazonian perspective, these responses are positive and open one up to deeper work with ayahuasca.
Ayahuasca experiences can be both very challenging and beautiful. Ayahuasca can draw attention to aspects of one’s life, leading to profound life changes and spiritual growth. This experience provides insight and meaning into how someone has arrived at their current life stage, often through what people describe as direct communication with the spirit of ayahuasca.

Preparation for Ayahuasca
A significant part of an ayahuasca experience is preparation. Ayahuasqeros – shamans who lead ayahuasca ceremonies – do extensive dietas (a period of lifestyle and dietary restrictions to prepare one for the ayahuasca experience). The shaman will often do this in isolation in the jungle to learn their craft, and it involves abstinence from sex, media, and many foods.
Participants in an ayahuasca retreat will be asked to undertake similar restrictions on food, sex, and perhaps other activities before consuming the psychoactive brew. A typical ayahuasca diet will restrict red meat, cheese, salt, sugar, and refined or fermented foods.
The ayahuasca diet is thought to increase one’s sensitivity to ayahuasca while removing distractions. The regime also includes mental preparation for what will likely be an intense experience. The diet also avoids potentially dangerous interactions with certain foods or medications. With ayahuasca in particular, certain medications (like antidepressants) must be avoided as they could cause harmful and possibly lethal interactions. The psychedelic researcher Kelan Thomas points out:
“The main risk is serotonin toxicity, which can occur when a drug that acts on the serotonin receptor — like SSRIs and many psychedelics — are mixed with a monoamine oxidase inhibitor (MAOI) that prevents the metabolism of serotonin.”
Since ayahuasca contains MAOIs, it should not be taken if you’re currently on any serotonin-focused antidepressants, such as SSRIs or SNRIs. This same risk is not present when taking psilocybin mushrooms, as these don’t contain MAOIs. However, the science is not so clear when it comes to whether certain foods restricted in the dieta interact with ayahuasca in a harmful way. For instance, members of the ayahuasca church União do Vegetal (UDV) don’t follow these dietary restrictions, as they don’t believe there is a significant risk involved.
Psilocybin – What to Expect
Psilocybin makes people highly sensitive to their environment and inner experiences. Small moments can seem huge and meaningful, while emotions can surface in powerful ways. With trained professionals to help prepare, navigate, and integrate a psilocybin experience, it is possible to harvest a significant amount of meaning from a psilocybin mushroom journey.
At this point in history, psilocybin is used in many different contexts. Indigenous practices and the history of psilocybin inform modern use, but the therapeutic use of psilocybin is generally very different from its traditional settings. Many practitioners still administer psilocybin mushrooms in ceremonial settings. However, psilocybin mushroom retreats in the modern world are increasingly evidence-based and supported by modern, therapeutic approaches.
Lessons learned from clinical trials with psychedelic-assisted therapy now inform the use of psilocybin mushrooms. Nowadays, many practitioners working with psilocybin have a mental health background. Similar to therapy, clients are guided through preparation and integration with an emphasis on the psilocybin experience. Practitioners are also trained in how to best support people during the session. While some have found personal growth through self-directed psilocybin journeying, we now know that the journey to healing from conditions like depression, anxiety, and addiction means including preparation and integration support from professionals.

Preparation for Psilocybin Mushrooms
Psilocybin mushrooms require significant mental and emotional preparation, but do not require a special diet or abstaining from sex. A high dose of psilocybin often generates intense challenges but may lead to profound cognitive insights, emotional breakthroughs, and mystical experiences. Taking the time to prepare one’s mindset before a psilocybin mushroom experience helps manage expectations, anticipate challenges, and put the mind at a bit more ease.
Preparing for a psilocybin retreat involves considering set and setting, establishing trust with facilitators and therapists, and establishing personal intentions. Most medications, like antidepressants, do not pose a serious risk but can diminish the effects of psilocybin. It’s recommended to discontinue medications with professional support before a retreat.
An ayahuasca diet might last for weeks, but before taking mushrooms, usually a few hours of fasting is recommended. Because psilocybin mushrooms can cause nausea, attention to food intake before the dose is important, although vomiting and diarrhea are rare. It’s thought that eating close to the time of consuming psilocybin mushrooms slows the onset of the experience, as it is metabolized more slowly.
In short, we can see that, when comparing ayahuasca and mushrooms, the latter usually involves less personal sacrifice and physical discomfort.
Choosing Between Ayahuasca and Mushrooms
The safety of both ayahuasca and psilocybin mushrooms has stood the test of time, particularly alongside skilled and professional facilitation. Choosing between ayahuasca and mushrooms means honestly considering your personal preferences for the set and setting best suited for you.
Ayahuasca vs. Psilocybin Retreats: An Overview of Legal, Therapeutic, and Cultural Factors
Ayahuasca can be accessed legally in numerous South American countries. Vetting shamans is essential because in parts of the world with less economic opportunity, poorly intentioned impersonators do take advantage of uninformed travelers. However, traditional shamans with good training and integrity help many people every year. Joining an ayahuasca retreat involves being open to interacting with a culture that is both ancient and unfamiliar. There may be language barriers, and understanding the worldview of people from the Amazon won’t happen during a short retreat.
The best ayahuasca retreats should be trauma-informed, but the quality of facilitation varies, so be sure to find centers with well-trained support staff, ideally with a mental health background. A safe ceremonial setting will be led by an experienced shaman, accompanied by a trustworthy support staff. It is essential to ask how many people will be at an ayahuasca retreat, as large groups can lead to less individual support and dramatically influence the dynamic of the experience.
Ceremonies are often led with prayers, medicine songs, icaros, tobacco, offerings, and other traditional healing technologies. Proper preparation before ayahuasca and integration afterward is essential for a safe and comfortable experience, which requires doing your homework to find trustworthy retreats, shamans, and facilitators.
Psilocybin can be accessed legally in a few countries, such as Jamaica and the Netherlands. Psilocybin retreats may draw some influence from traditional use, but practitioners utilizing psilocybin typically work through a psychological or transpersonal lens. Using relatable concepts and language helps people from Western countries prepare for, integrate, and ultimately understand their psilocybin experiences.
Psilocybin retreats should also be trauma-informed, and many still lack the necessities for the best care. The highest-quality retreats employ facilitators with strong mental health backgrounds and maintain retreat sizes that are optimal for the number of staff to provide the proper level of support.
MycoMeditations Psilocybin Retreat
The MycoMeditations experience provides numerous trained therapists to best care for guests seeking psychedelic-assisted therapy with a modern approach. People can receive psilocybin therapy in an intimate setting with a maximum of 12 guests and a high staff-to-guest ratio of approximately 1:1.5. Each day, hours of preparation and integration are provided to ensure that guests receive the most healing from their psilocybin experiences, along with integration support once they return home.
If you’d like to learn more about MycoMeditations, we invite you to explore the rest of our website and apply if you wish to join us on a retreat.
A Complete Guide to Psilocybin Therapy in Oregon
The therapeutic potential of psilocybin continues to gain attention worldwide. Clinical trials further highlight the potential of psilocybin therapy each year, with increasing mentions of psilocybin and other psychedelic drugs in the research literature as this “breakthrough therapy” surrounding psychedelic substances emerges in the mainstream.
Psilocybin mushrooms are a powerful tool for overcoming depression, anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, and many other mental health challenges. People want to access these therapies more than ever.
In the United States, each year has new states moving legislation forward to eventually allow for legal psilocybin sessions to be accessed. Oregon passed Measure 109 in November 2020 to permit the regulated medical use of psilocybin under the supervision of trained and licensed facilitators in licensed service centers. Since then, Oregon Psilocybin Services has implemented rules and regulations for providing therapeutic services involving psilocybin, resulting in a growing number of companies offering legal psilocybin therapy in Oregon and people traveling from abroad to access these services.
The Legal Framework and Regulations for Psilocybin Therapy in Oregon
The official regulations, as overseen by the Oregon Health Authority, outline specific guidelines regarding the dosage of psilocybin, facilitator training, the environments in which sessions can take place, and the criteria for client eligibility. You can also monitor all available data from the Oregon Health Authority’s data dashboard for psilocybin services, where you can gather information regarding everything from licensing, compliance, to safety standards surrounding psilocybin therapy in Oregon.
While we at MycoMeditations welcome legalization that allows for psychedelic therapy to improve the mental health crisis, our experience of providing over 6000 psilocybin therapy sessions allows us to see the limitations of the regulatory framework informing the protocols for psilocybin retreats and psilocybin therapy in Oregon, which we will share below.
Exploring Psilocybin Therapy in Oregon
We understand that it can feel risky to travel somewhere new and invest thousands of dollars in the hope that a new therapy can aid in emotional healing, helping you address the root of the challenges you may face in your daily life. Or perhaps your struggles with a mental health disorder are so severe that you think you have no other options.
We hope that this article can point you in the best direction and provide you with important considerations before making any decision, especially if you are already considering signing up for psilocybin therapy or a psilocybin retreat in Oregon.
Psychedelic-assisted therapy is a powerful experience that requires the utmost trust in those supporting you. This overview also provides information about some of the psilocybin service centers available there.
If you wish to explore these companies further, we recommend conducting additional research, asking questions, and determining if they are the right fit for you. Contact the psilocybin therapy centers in Oregon that interest you and speak with them directly to gain a better understanding before making any decisions. You can take a look at the Oregon Psilocybin Services Licensee Directory to conduct further research.
Please note that MycoMeditations does not endorse the retreats and centers listed below; this guide is intended to consolidate possible options for individuals seeking psilocybin therapy in Oregon.
Psilocybin Therapy Centers in Oregon
Innertrek
InnerTrek provides psilocybin therapy services and offers facilitator training programs approved by the Oregon Health Authority. Their training program was the first government-approved psychedelic training program in the United States.
This center emphasizes the importance of communal experiences in the healing process, making it an option for those who value shared journeys. InnerTrek offers single-day group sessions priced between $1,200 and $2,000, with an additional cost of up to $100 for psilocybin. Their three-day group retreats are available for $2,500, which consists of one session. Innertrek’s single-day group sessions provide two online preparation and integration sessions, and the retreats also include preparation and integration while on the retreat.
Their psilocybin therapy center in Portland is located in the downtown area, offering options for nearby accommodations if you are traveling from outside of Portland.
Epic Healing Eugene
Epic Healing Eugene provides both private and group psilocybin therapy in Eugene. It was also the first legal mushroom therapy center in Oregon
Individual sessions consist of three hours dedicated to preparation sessions followed by two hours of integration. They also offer quarterly mini psilocybin retreats in Eugene. The cost of single-dose psilocybin therapy ranges from $2,200 to $2,800, and two-dose packages range between $3,600-$4,600, depending on the facilitator.
Small group experiences will cost you $1,800 for a single session. Their psilocybin doses appear to be very low when done in their retreat setting. Located in the heart of Eugene, it serves as a convenient option for those looking to explore psilocybin therapy in urban settings.
Psilocybin Retreats in Oregon
Odyssey
Odyssey is one of the more well-known psilocybin retreats in Oregon, offering both private and group retreat options. Their center is located outside of the city and provides a beautiful setting to complement your psilocybin retreat experience.
Their private retreats are custom-curated over two or three days with a wide range of prices. The private retreats include one psilocybin session with a couple of hours of preparation and integration support around the session. The group retreats are all-inclusive with meals and lodging.
Their prices range anywhere from $3500-$6500, depending on the accommodations selected and if you choose a private or group psilocybin retreat experience. The retreats are three nights and include one psilocybin session with preparation and integration. If you have a higher budget and are looking for a more nature-based psilocybin retreat in Oregon, you may want to take a look at Odyssey.
Confluence
Confluence provides psilocybin retreats in Ashland, offering a range of services that take place in different settings. They offer private single-day psilocybin sessions, 3-day private retreats, or 5-day group retreats.
The single-day sessions take place in a private room within their licensed psilocybin service center. The psilocybin session is accompanied by a therapy session and breathwork session prior to the dose, and two integration calls following the dose. The price is $2250. The 3-day private retreats take place in the outdoor surroundings of Confluence’s healing center and involve one psilocybin session. Breathwork and meditation sessions are a part of the preparation and integration experience.
The price for this service is $3900. Their 5-day group retreats also take place within natural surroundings at the healing center and include two psilocybin sessions. Similar to the private retreats, preparation and integration are offered to complement the psilocybin journeys. Prices start at $5900. Those with a larger budget for a psilocybin retreat in Oregon may be interested in researching Confluence.
Limitations of Psilocybin Services in Oregon
While Oregon has taken a progressive step by legalizing psilocybin therapy, our experience suggests that the state’s regulations have some key shortcomings, which you may want to consider before deciding where to receive psilocybin therapy in Oregon.
The Maximum Psilocybin Dose May Not Be High Enough for Some People
The limit for the dose of psilocybin that can be provided is 50 milligrams of psilocybin, which amounts to about a 6-gram equivalent for whole psilocybin mushrooms. While this is a substantial dose by many people’s standards, when trying to maximize the effects of psilocybin as a legitimate medical treatment for a range of mental health conditions, this 6-gram cap will limit the effectiveness of Oregon’s psilocybin therapy model.
Capping maximum doses at 6 grams for psilocybin treatment will be one of the most significant limitations to psilocybin-assisted therapy in Oregon. This restriction will pose a hindrance to individuals suffering from treatment-resistant depression or complex forms of anxiety.
This is especially relevant considering that people participating in psilocybin therapy in Oregon are not required to wean off antidepressants, and these medications are shown to diminish the potency of psilocybin.
In our experience, individuals with treatment-resistant, long-standing mental illness often need doses higher than 6 grams to disrupt deeply rooted neural and psychological patterns.
Longitudinal survey data from our guests shows lasting improvements in depression, generalized anxiety, social anxiety, and PTSD when using higher doses. These results would be unlikely using smaller doses, as many guests report their breakthrough in the second or third dose, where the dose is typically higher than 6 grams.
When these experiences are navigated and supported effectively, high-dose psilocybin sessions, exceeding 6 grams, can lead to significant changes, improvements, and relief.
In a research article published in 2024 in Drugs: Education, Prevention and Policy, Jesper Dunnell explores psychedelic retreat experiences aimed at promoting personal growth. He observes how some participants at legal psychedelic retreats involving magic truffles would take quite high doses:
“During the ceremonies, the participants ingested large doses of psilocybin truffles. The doses were adapted to each participant but were on average 15–25 grams for the first ceremony and 20–50 grams for the second ceremony. Some participants consumed additional doses.”
50+ grams of magic truffles is a strong dose – higher than the equivalent of 6 grams of dried psilocybin mushrooms. Some people desire and need doses of this sort to reach the depth of experience and healing they’re looking for. Many psychedelic retreats using magic truffles recognise that people’s sensitivity to psychedelics differs, as does the nature of their emotional distress. Limiting the high-dose end of psilocybin sessions in Oregon, therefore, limits opportunities for healing and growth.
Lack of Therapeutic Background Requirements and Relatively Little Training Needed to Be a Licensed Psilocybin Facilitator
Regulations for psilocybin therapy in Oregon also do not require licensed psilocybin facilitators to possess therapeutic credentials to gain their license. The hours of training required to become licensed are minimal, with only around 200 hours between classroom hours, supervised practicums, and consultation.
It also requires no direct, personal experience with psychedelic mushrooms. This aspect has sparked conversations about the aptitude and qualifications of facilitators guiding psilocybin sessions in Oregon.
With society attempting to carve out a role for psychedelic therapy within our mental health treatment systems, there needs to be a greater emphasis on training therapists and facilitators rather than rushing to provide access. We believe that experiential training that utilizes psilocybin is a crucial component in practitioners gaining the necessary expertise. This will maximize its positive impact and reduce adverse reactions.
While the legalization of psilocybin therapy in Oregon is commendable, shortcomings in the state’s regulations emphasize the need for future adjustments and improvements.
A 2024 article published in Nature Medicine raises concerns about the lack of adequate training for psilocybin facilitators in Oregon. This could put participants’ safety at risk. The authors state:
“Oregon’s training requirements may be insufficient to enable facilitators to individualize screening and monitoring effectively, without medical oversight. Facilitator licensure requires a high-school degree and at least 120 hours of instruction (including 12 hours on safety and ethics and 4 hours devoted to the underlying science and state of research) plus 40 hours of practicum training. This training is unlikely to enable competent judgments regarding subtle psychiatric or physical symptoms characteristic of mania, psychosis, suicidality and cardiovascular disease. Oregon could mandate specific monitoring and emergency protocols, including specific signs and symptoms requiring medical evaluation and availability of clinicians who can be consulted quickly.”
You may be interested in reading this full side-by-side comparison of psilocybin services in Oregon vs. Jamaica, another location for legal psilocybin services, where the providers are free to work with their own standards and protocols.
Other Popular Destinations for Psilocybin Retreats
Many people considering psilocybin therapy for mental health issues are unaware that there is already an established psilocybin industry in Jamaica and the Netherlands, which have allowed psilocybin to be consumed legally for decades.
There are many psilocybin centers in these countries, being the first providers to offer these services legally at their own psilocybin centers. Psilocybin therapy in Jamaica and the Netherlands is typically undertaken in retreat settings as opposed to the more clinical/office-bound sessions offered in Oregon.
Netherlands
Psilocybin retreats in the Netherlands are legally offered through a unique framework that allows for the use of psilocybin, but only in truffle form. Psilocybin mushrooms are, in fact, illegal here, which has always perplexed people, as magic mushrooms and truffles contain the same psychoactive compounds. These retreats are typically run by facilitators from a range of professional or therapeutic backgrounds who focus on creating a safe and supportive environment for participants.
Jamaica
There are numerous options for psilocybin retreats in Jamaica, just like there are in Oregon or Colorado. There is also a broad range of retreats available, with frameworks ranging from those with a wellness focus to those that are more therapeutically oriented. As a result, the quality of psilocybin providers in Jamaica varies dramatically.
MycoMeditations offers a compelling alternative for those seeking a more comprehensive psilocybin therapy experience. MycoMeditations was the first psilocybin retreat in Jamaica to open its doors, and is likely the only psychedelic retreat in the world that provides actual psychedelic therapy through our unique retreat model.
Our retreat has been continually developed and refined since its inception in 2014, hosting thousands of guests. With the freedom to develop and uphold standards based on what is proven to be effective, we set out with the goal of creating the gold standard for what a therapeutic psychedelic retreat can be. Our 3-dose psilocybin treatment model led by licensed therapists allows people to go deeper in their healing than in the clinical setting or at other retreats, where you will rarely work with more than a single session. This, combined with our experience of working with higher doses than typically offered, has drastically improved the lives of those who joined us with crippling cases of depression, anxiety, and more.
If you have thought about participating in psilocybin therapy in Oregon, we invite you to first browse through our website to learn about the most mental health-oriented psilocybin retreat available. Feel free to book a call with us to explore if one of the most experienced psychedelic retreats in the world may actually be the option that serves you best.
Comparing Microdosing Psychedelics to Psychedelic Therapy
Living with depression, anxiety, PTSD, and other mental health challenges can be incredibly difficult. Many people have tried conventional treatments for years, or even decades, with little success. Psychedelics are gaining traction as a way to tackle these challenges better, and various options ranging from microdosing protocols, ayahuasca retreats, ketamine clinics, and psilocybin retreats are emerging for people to try.
Microdosing in particular has gained popularity as a way for people to try and experience the potential benefits of psychedelics, magic mushrooms in particular, in an attempt to improve their mental health. News outlets from The Guardian to The New York Times and National Geographic have written extensively about this growing trend, and microdosing retreats for mental health issues have started to appear as discussions of psilocybin-assisted therapy become more mainstream.
But microdosing has its limits. Read below to learn the differences between microdosing and psychedelic therapy. This will help clarify why most psychedelic retreats exclusively use what, instead, might be called “macrodoses” (i.e., larger doses of psilocybin mushrooms or other psychedelic medicines) instead of microdosing.
Microdosing vs. Psychedelic Therapy: An Overview
Microdosing involves taking sub-perceptual doses of a psychedelic, typically a classic psychedelic like psilocybin mushrooms or LSD. ‘Sub-perceptual’ means that the dose is small enough so that no perceptual effects occur, such as visual distortions. However, a microdose also means that other classic psychedelic effects will be absent, including intense emotions, laughing fits, deep introspection, or even mystical experiences.
Many people opt for microdosing as a less intense way to address mental health issues. Others claim it helps enhance other aspects of life, such as focus, concentration, mindfulness, creativity, productivity, and relationships.
Psychedelic therapy, in contrast, involves working with macrodoses. These are doses high enough to induce classic psychedelic effects. The primary motivation for choosing psychedelic therapy is to alleviate a mental health condition. Nonetheless, other benefits may arise, such as an enhanced sense of meaning, purpose, and spirituality.
A key difference between microdosing and psychedelic therapy is that, in the former, you take the dose on your own and then go about your day. In the latter case, you take the dose in the presence of one or more therapists. In psychedelic therapy, you lie down with an eye mask and headphones on, playing a pre-selected playlist. It’s very much a deep, internal experience. The effects are typically strong and highly pronounced, so it’s important to have one or more facilitators present for psychological support.
Since microdosing creates more subtle effects, you should be able to function as you usually would. You don’t need a facilitator or guide present with you to offer emotional support or guide you through the experience when microdosing.

Supposed Effects of Microdosing: Does it Work?
Researchers have studied the claimed benefits of microdosing, and the results are mixed. Survey-based studies have found that people who microdose experience mental health benefits, such as reduced depression and anxiety. Observational studies provide the same evidence: microdosers experience greater improvements in mental health than non-microdosers. Nevertheless, these studies have methodological limitations. They don’t demonstrate that microdosing itself causes these benefits.
Indeed, if we look at placebo-controlled studies on microdosing, which involve a more rigorous methodology, we find that there’s no significant difference between taking a microdose and a placebo. In other words, the placebo effect—the expectation of a benefit leading to that benefit—helps explain why microdosing works for many people. However, one placebo-controlled study did find that microdoses of LSD reduced pain perception more than a placebo.
The supposed convenience of avoiding challenging psychological experiences with smaller doses of psychedelics can also make microdosing a less-than-ideal psychedelic treatment. To reap the real mental health benefits of psychedelic therapy, people often need to face challenging or even frightening psychological experiences. Taking high doses of psychedelics is what allows people to access trauma at its core, where it can be processed. Microdosing simply does not get people there.
The potential benefits of taking a high dose of psilocybin when done intentionally in a safe, supportive setting with time to effectively integrate the experience far outweigh the subjective effects that come with microdosing.
So, how would we compare microdosing with psychedelic therapy done at a psilocybin-assisted retreat? Are you considering trying a microdosing retreat? Continue reading to learn the differences between microdosing and psychedelic therapy.
Microdosing vs. Psychedelic Therapy with Psilocybin Mushrooms: The Difference is in the Dose
Instead of taking sub-perceptual amounts of psilocybin mushrooms (0.1g–0.2g) as with microdosing, psilocybin retreats provide guests with high doses, possibly anywhere in the range of 3-15g of dried psilocybin mushrooms during their stay. These dosing ranges are what many people would describe as a “heroic dose”. The amount may increase in this range throughout the retreat week with each of the dosing sessions. While psychedelic therapy typically involves high doses of psilocybin, such as 25 mg, doses of dried psilocybin mushrooms at retreats often exceed this dose of pure psilocybin.
The dosage used at a psychedelic retreat depends on many personal factors for each guest, which are determined through each retreat’s unique protocol. Some retreats may have standardized dosing, while others tailor the dose to the individual needs of each guest.
Facilitators take into account an extensive list of factors to decide the optimal psilocybin therapy dose for each individual, such as sensitivity to various substances or medications, personality type, mental health status, trauma history, inner psychological resources, and past use of psychedelics.
Why do many psilocybin retreats work with such high doses? As a psilocybin retreat center, we repeatedly see that people with intractable cases of depression and anxiety simply need to be pulled out of the negative mental pattern they are stuck in, which is only accomplished by larger doses. This is where the Default Mode Network, or “DMN,” comes in.

Microdosing vs. Psychedelic Therapy: Activity in the Default Mode Network
The Default Mode Network describes the state of our brains when we are at rest. The DMN is often associated with activities such as daydreaming and self-reflection. For many people with mental health conditions such as depression or anxiety, a hyperactive DMN essentially causes them to get stuck in negative ruminations. This involves spending an unhealthy amount of time replaying distressing thoughts related to themselves, their lives, other people, and the world around them.
Psilocybin has been shown to reduce activity in the Default Mode Network, allowing the brain to create new neural connections. This process is greatly enhanced when taking larger doses compared to microdosing. With the DMN offline, people have a window for novel experiences. They can learn to better relate to themselves, others, nature, or society. This rich, new experience then factors into the brain’s neural connections when the DMN comes back online. With effective psychedelic therapy and integration, the Default Mode Network takes this fresh experience into account and helps the individual find a “new normal”.
In contrast, there’s no evidence that microdosing can affect the DMN in the same way that psychedelic therapy can. It requires a macrodose to enact significant changes in this brain network. While microdosing may enhance neuroplasticity—increasing neural connections, which can benefit mental health—the positive aftereffects of significantly reducing DMN activity are missed.
Microdosing vs. Psychedelic Therapy: Positive Effects of Higher Dose Magic Mushroom Sessions
Psilocybin-assisted retreats also create cathartic psychological experiences, which is the same result of psychedelic therapy in a clinical setting. Besides the process involving the Default Mode Network, psilocybin also acts as a chemical key to open people up to deeper layers of the mind, which isn’t possible in the same way with microdosing.
With higher doses of psilocybin mushrooms, many of the emotions and feelings that have been subdued, ignored, or forgotten begin to emerge. These are often experiences that stem from childhood and our earliest encounters in life. High-dose psychedelic therapy gives someone hours to work with their deepest, core emotions and memories. During this time, an extraordinary amount of healing can be done. Microdosing simply will not open you up to this level of depth or provide the same level of therapeutic benefits.
Here’s an analogy to describe macrodosing experiences: Imagine the various layers of soil as your mind. You have the topsoil down to the bedrock. Microdosing can facilitate work at the uppermost layers, as it can activate new perspectives and insights, creating subtle shifts. Whereas with psychedelic therapy, providing larger doses of psilocybin is like drilling into the bedrock. These deeper layers (of our psyche) are where our problems stem from and where trauma is buried.
High-dose psychedelic therapy aims to go to the root cause of psychological suffering, including dealing with traumatic experiences. To cope with trauma, an individual’s psyche often uses defense mechanisms such as repressed memories or dissociative amnesia. It is much more difficult to move past these barriers with microdosing.
Dealing with Psychological Effects and Challenging Experiences
Of course, high-dose psilocybin experiences can be challenging and frightening. That is why psilocybin retreats should have trained therapists and facilitators and provide guests ample time each day to reflect and integrate their experiences.
Microdosing may ensure you won’t have difficult experiences. However, finding the courage to face uncomfortable feelings is often necessary for healing. Indeed, research by Griffiths et al. (2016) found that many people view their most challenging psychedelic experience as highly meaningful and spiritual, and that it led to an improved sense of well-being or life satisfaction.
That isn’t to say that these profound experiences on high doses of psilocybin mushrooms always have to be difficult—often, they are the most blissful experience someone will ever have. The key is being prepared and supported, because the therapeutic outcomes can be tremendous with high-dose work.
The Risks of Psychedelic Therapy
It’s important to acknowledge that working with high-dose psychedelic therapy can involve certain risks. For example, a small minority of people in the Griffiths et al. study sought treatment for the enduring distress they experienced after their challenging experience. More recent research has also brought to light the extended difficulties that some people experience after intense psychedelic journeys. Nonetheless, the majority of these difficulties occurred in an uncontrolled setting, without therapeutic intent or a guide present.
This is why any legitimate psychedelic retreat should only work with highly trained and vetted facilitators. It also underscores the need for a controlled setting, proper screening, preparation, psychological support during sessions, and post-session integration. This ensures that, should difficult emotions arise during a session, they can be addressed and worked through effectively. This helps to both maximize the potential benefits of these experiences and minimize the risks involved.
The Risks of Microdosing
The potential risks of microdosing aren’t discussed enough. So far, the evidence shows that psychedelic therapy is physically safe. Taking macrodoses of psychedelics is non-toxic—it doesn’t cause damage to any of the organs.
On the other hand, psychedelic researchers such as Kelan Thomas have raised concerns about chronic microdosing, that is, microdosing two, three, or more times a week, for several weeks or months, which is what microdosing regimens typically recommend. Thomas and other researchers worry that this may put heart health at risk. This is because classic psychedelics activate the serotonin 5-HT2B receptor, and other drugs that frequently activate this receptor have been shown to increase the risk of valvular heart disease (VHD).
Of course, we need more evidence to establish the link between long-term microdosing and effects on the heart.
We hope this helps you understand the differences between microdosing and psychedelic therapy, and why we focus on psychedelic therapy at MycoMeditations. At the end of the day, regardless of whether you choose to explore a microdosing retreat or a high-dose psilocybin retreat like ours, healing is defined by nobody besides you.
Overview of Psilocybin Retreats and Psychedelic Therapy in Colorado
Psilocybin-assisted therapy is making waves in mental health and wellness, and the state of Colorado has taken a historic step forward in making psychedelic therapy in the US available. Starting January 1, 2024, psilocybin-assisted therapy has been legalized in the Centennial State, positioning Colorado as a leader in the growing movement to integrate psychedelic medicines back into our culture under regulated therapeutic applications after decades of prohibition.
For mental health advocates and psychedelic therapy enthusiasts, this is cause for celebration. Following years of studies through clinical trials at Johns Hopkins, Columbia, and many other renowned universities, new psychedelic clinics and psychedelic retreats in Colorado have emerged, broadening access to these treatment options. This offers exciting options for those hoping to explore psilocybin mushrooms as a breakthrough therapy for assistance in overcoming everything from treatment-resistant depression to post-traumatic stress disorder.
But as groundbreaking as it is, psychedelic therapy in Colorado still comes with limitations. This article will explore the regulatory framework surrounding psychedelic retreats and psilocybin therapy in Colorado, comparing them with those in Oregon. We also highlight early treatment options and offer balanced insights into the challenges that seekers of personal growth through psilocybin experiences may face.
Understanding Psilocybin Therapy in Colorado
Legal psilocybin therapy in Colorado involves a mix of decriminalization and structured frameworks for therapeutic use of natural medicines such as mushrooms. The decriminalization of psilocybin in Colorado dates back to 2022, when a passing vote for Proposition 122 allowed individuals over 21 to use and share certain psychedelic chemical compounds without criminal penalties. The state has now established formal regulations for trained mental health practitioners and licensed healing centers to administer psychedelic therapy in Colorado.
Key Regulations for Psilocybin-Assisted Therapy in Colorado
Oversight of legal psilocybin therapy in Colorado falls to the Department of Regulatory Agencies (DORA). DORA’s responsibilities include regulating natural medicine services through the issuance of healing center licenses, facilitator certifications, cultivation permits, and reporting guidelines, among other tasks. Here’s what that means for clients seeking psychedelic therapy in Colorado:
- Healing Centers: Colorado will license physical spaces where psychedelic administration sessions can be legally provided. These include urban clinics and rural retreats, with unique zoning rules determined by city councils that vary by municipality.
- Psilocybin Facilitators: Licensed facilitators can lead psilocybin therapy in Colorado, and only in this state. To earn certification, facilitators must complete a process of state-approved training programs, pass competency exams, and renew their licenses regularly by paying licensing fees.
- Controlled Supply Chain: From cultivation to testing, all psilocybin products used within licensed programs must meet strict safety and quality standards.
- Tracking and Reporting: Colorado’s psilocybin healing centers must keep in-depth records, including, but not limited to, reporting all adverse guest experiences to the state.
These measures promote safety and standardization, providing individuals with greater confidence when seeking psilocybin therapy in Colorado. This sets clear expectations for every stakeholder and ensures that psilocybin services in Colorado meet a high standard of quality and professionalism.
How Psychedelic Access in Colorado Differs from Oregon
Colorado is following Oregon’s lead in introducing legal psychedelic substance access, but with a few notable distinctions in its regulatory approach:
- Vertical Integration: Psychedelic therapy in Colorado favors a vertically integrated model where healing centers manage several parts of the supply chain. Oregon, by contrast, splits licensing into four separate categories.
- Flexible Locations: Psilocybin services in Colorado are available in non-center settings, including private residences (resulting from decriminalization) and healthcare facilities, offering more options for guided therapy.
- Expanded Psychedelics: Colorado’s framework allows for additional psychedelic substances to become available over time.
- Decriminalization Differences: Colorado’s overarching policy provides broader protections for personal psilocybin use compared to Oregon’s more restrictive decriminalization protocols.
- Local Bans: Unlike Oregon, Colorado doesn’t permit municipalities to entirely ban healing centers within their jurisdiction.
As US states continue to legalize psychedelic-assisted therapy, the rules and regulations for each will vary as regulatory bodies attempt to best integrate medicines such as psilocybin mushrooms into traditional psychotherapy to treat mental illnesses.
Options for Psilocybin Therapy in Colorado
For those considering psilocybin therapy in Colorado, here’s a brief overview of notable clinics and retreats.
Please note that MycoMeditations does not endorse these providers. This is simply a list of early examples of what’s currently available in the state upon legalization.
Psychedelic Clinics in Colorado
- Medicinal Mindfulness: A non-profit offering “supported personal use” services and guided psychedelic experiences facilitated by trained professionals.
- Wholeness Center: Integrating psychedelic care with natural treatment options, the clinic has experience with ketamine-assisted therapy and harm-reduction approaches for psilocybin.
- Reflective Healing: Offers guidance and therapeutic integration for individuals exploring decriminalized psilocybin use.
Psychedelic Retreats in Colorado
- Odyssey PBC: Led by standard clinical research, Odyssey provides private sessions and group retreats.
- Ceremonia: Combining science and spirituality, Ceremonia hosts psilocybin retreats centered around plant medicine ceremonies.
Before You Decide: The Limitations of Colorado’s Program
Colorado’s psilocybin therapy legalization marks significant progress towards larger access to psychedelics, but prospective clients should understand that there are certain limitations to consider before making this huge personal decision. Here are key points to consider:
Limited Practitioner Experience
Many psilocybin facilitators in Colorado are relative newcomers to psychedelics and their therapeutic applications, especially when they’re offered to address severe mental health challenges such as treatment-resistant cases of depression or anxiety. There is little experiential training in those who are becoming licensed, and direct, hands-on experience is the most important type of experience to look for when researching psychedelic guides in Colorado.
We also recommend that you take note of where psilocybin facilitators studied, as psychedelic therapy training schools differ in how they teach students to handle people’s psychedelic experiences.
Dosing Amounts
Psychedelic therapists in Colorado will likely remain conservative in their dosing protocols due to dosing limits. Effective psilocybin therapy can require a higher dose of psilocybin than most are equipped to provide and must be administered by experienced professionals to achieve safe, transformational breakthroughs.
For instance, participants at psilocybin retreats in the Netherlands take relatively high doses of magic truffles (up to 40 grams, which is equivalent to a high dose of dried psilocybin mushrooms). Specific psilocybin retreats in Jamaica work with even higher doses to assist those with mental health conditions. The option for high-dose experiences often means that those with a lower sensitivity to psychedelics or deeper forms of emotional distress can achieve the kind of therapeutic experiences they’re looking for.
New-Age Culture
Many traditional, trained psychedelic practitioners in Colorado orient their guidance and support through spiritual frameworks that often don’t align with the beliefs of the typical American client seeking psilocybin-assisted therapy. Finding facilitators who respect your belief systems and commit to working with you through that lens is crucial for a safe and grounded experience.
In a 2020 paper published in ACS Pharmacology and Translational Science, psychedelic researcher Matthew Johnson raised concerns about the influence of specific spiritual ideas in psychedelic therapy. He writes:
“It is important to operate … from a secular framework that is nonetheless open to working with patients or participant[s] of any religious/spiritual background. This is in alignment with the best practices of clinical psychology and other mental health professions that recognize the importance of strong rapport with patients, religious/spiritual tolerance, and the importance to mental health of having meaning in life…
Patient beliefs often play a large role in her or his meaning making from sessions. Just as with the practice of secular clinical psychology or psychiatry, a patient can certainly bring up religious beliefs and concepts in therapeutic discussion, e.g., Buddha, Christ, kundalini, and plant spirits, but it is not the role of the clinician or scientists to introduce such concepts. The goal of the clinician should be a create an open and supportive environment where the patient can make her or his own meaning, if any, from such experiences.”
Because of the limitations of Colorado’s psychedelic therapy program, it’s essential to take the time to conduct thorough research before committing to any clinic or retreat. This involves looking into the qualifications and experience of the staff, reading reviews or testimonials from previous clients, and confirming whether the facility aligns with your specific needs and goals.
Additionally, researching the methods or treatments offered can help ensure they are evidence-based and reputable. Taking these steps can provide peace of mind and increase the likelihood of a positive and effective experience.
The Gold Standard of Psychedelic Therapy
While psychedelic-assisted therapy in Colorado is an attractive option, people serious about psilocybin therapy should consider MycoMeditations, the original legal psilocybin therapy retreat. Located in Jamaica, where psilocybin is fully legal, we have spent over a decade refining our personalized approach to provide an unparalleled level of mental health support through psychedelic experiences. Our program is designed to be the gold standard for what psychedelic care applied to mental health can look like. Here’s what sets us apart:
- Experience Matters: With over 2,000 guests served and more than 6,000 therapy sessions conducted, MycoMeditations is the most experienced psilocybin therapy retreat in the world.
- Ideal Application of Psilocybin: Our week-long retreats include three guided psilocybin sessions, allowing for deeper healing than standalone experiences. Our protocols and practices also allow us to safely administer higher doses of psilocybin, which can often be a requirement for people in a mental health crisis.
- Mental Health-Focused: We have developed a reputation for being the retreat people go to when they need to work with psilocybin for depression, anxiety, PTSD, OCD, and more. Our team is highly experienced and has undergone rigorous training to provide the deepest level of psychedelic psychotherapy when you join us on retreat.
- Proven Results: Guests who join MycoMeditations experience clinically significant improvement across numerous mental health conditions, including major depression, generalized anxiety, social anxiety, and PTSD, validated by multiple years of post-retreat surveys verified by a neutral third-party.
- Legal Framework: Enjoy complete peace of mind knowing psilocybin retreats in Jamaica are completely legal. Psilocybin is not simply decriminalized, regulated through a gray market, or prohibited by federal law, as is the case with many other access locations.
- Tailored Support: From dosage adjustments to personalized integration, our experienced psilocybin facilitators address each guest’s unique needs with compassion and expertise within an immersive, week-long therapeutic experience.
Our full-service psilocybin retreats in Jamaica are dedicated to providing therapeutic doses of psilocybin mushrooms under the guidance of trained, experienced therapists. These therapeutic mushroom experiences take place in a serene, tropical backdrop, which is as close as it gets to the ideal setting for psychedelic therapy. With a proven track record of life-changing transformations, MycoMeditations offers an unmatched experience with psilocybin, all within the beauty of the Caribbean, away from everyday life, to focus closely on your healing.
Explore the benefits of psilocybin therapy with the leading experts in this field. Look through our website to learn more and apply for an upcoming retreat. The next chapter of your life awaits.
How Psychedelics Can Assist with End-of-Life Distress
You’ve probably already heard about the healing potential of psychedelic-assisted therapy for mental health. Still, modern research into compounds like psilocybin and MDMA doesn’t just focus on depression, anxiety, or PTSD. Some of the most profound results for psychedelic medicines come from addressing the spiritual well-being of those experiencing emotional suffering at the end of their lives. Indeed, we are seeing a lot of promise in the use of psychedelics for end-of-life distress.
At MycoMeditations, we draw upon the insights gained from the last 20 years of medical research to offer compassionate, therapeutic psilocybin retreats for individuals experiencing end-of-life distress. These retreats are not just intended for sufferers themselves, but also for spouses, friends, and family members. Together, loved ones can offer support during the most emotionally and spiritually trying ordeal a person can experience, as well as process their own feelings about the impending loss of someone important to them through psilocybin-assisted therapy.
What is End-of-Life Distress?
Death is frightening. Fear of death is perfectly natural. Whether or not you hold spiritual or religious beliefs about the soul or an afterlife, it is normal to feel significant unease and anxiety at even the thought of death and dying. Most of us do our best in daily life to avoid contemplating our own mortality.
A terminal diagnosis makes this impossible. Cancer patients or sufferers from other terminal conditions who are told their lives will end and that their time is now limited report intense feelings of distress, including feelings of terror, dread, grief, and overwhelming anxiety. They experience this not just for themselves but also for their families, friends, and loved ones. The reality of their impending death becomes all-encompassing, compounding the tragedy of a terminal diagnosis by robbing individuals and families of their quality of life, bringing on intense bouts of anxiety and depression during the time they have left together. These overwhelming emotions are referred to collectively as end-of-life distress.
The therapeutic use of psychedelics for end-of-life distress may be an option when other treatments have failed to provide adequate relief. As we will see below, researchers are discovering potential links between psychedelics and palliative care.
If palliative care is meant to offer psychological and spiritual support for patients, psychedelic retreats will likely play a significant role in it. This is because, in supportive contexts, psychedelic therapy allows people to confront and resolve difficult emotions connected to the process of dying. Additionally, psychedelics can evoke mystical experiences, which provide lasting meaning and changes within people. This is particularly fitting for people with end-of-life distress, as mystical experiences are directly connected to the immense existential topic that they are navigating as they near death.
Psychedelics for End-of-Life Distress: Scientific and Legal Perspectives
Much of the modern psychedelic research and legal action around psychedelics for end-of-life distress stems from the work of Dr. Roland Griffiths at the Johns Hopkins Center for Psychedelics and Consciousness Research. Prompted by the positive results of a 2006 investigation into the effects of psilocybin for end-of-life distress in healthy subjects, Griffiths and his team continued and intensified their investigations into psychedelic-assisted psychotherapy. This covered the potential for spiritual experiences, as well as the treatment of mental health issues such as addiction, depression, and end-of-life distress for cancer patients.
Psilocybin therapy for end-of-life distress has played a significant role in the current psychedelic renaissance outside of academia.
In early 2020, the Canadian government made history by granting compassionate access to psilocybin for end-of-life distress for four patients who were terminally ill. While still strictly controlled and limited, access has since expanded over the last few years. Even non-terminal patients can apply to be treated with both psilocybin and MDMA under Health Canada’s Special Access Program, where access to psychedelic substances for psilocybin or MDMA-assisted therapy is approved by the government ministry on a case-by-case basis.
That said, Canada’s Special Access Program for terminally ill patients to receive psychedelic therapy has been controversial since its release.
Prominent lawsuits in both the US and Canada have sought to force the United States Drug Enforcement Administration (DEA) and the Federal Government of Canada, respectively, to allow increased access to psilocybin for terminal patients.
Numerous Canadians have filed a federal Charter challenge against the Canadian government due to restrictive access, claiming the current avenues for accessing psychedelic therapy violate the Canadian Charter of Rights and Freedoms.
Canada’s largest psychedelic advocacy group, TheraPsil, is supporting these Charter challenges as TheraPsil has been central in assisting Canadians to secure legal access to psychedelic therapy, particularly for end-of-life distress.
Dr. Sunil Aggarwal of Seattle has spent years attempting to force the DEA to allow terminal cancer patients access to psilocybin therapy for end-of-life distress under provisions of the 2016 Right to Try Act. After a lengthy process, a federal court upheld the DEA’s denial of Aggarwal’s request to use psychedelics for end-of-life distress.
Psychedelic Retreats, Palliative Care & Death Doulas
Psilocybin research is only one facet of how our societal conversation around death is changing. While still a taboo subject, death and dying are now more open to discussion. Most of the more institutionally ingrained taboos that dictate the “right” or “wrong” ways to deal with death and beliefs in life after death are gradually fading away, leaving us with questions about how to process our emotions.
Counseling and psychotherapy can focus specifically on death, terminal diagnoses, and family coping, all of which reflect a broader cultural movement towards embracing and understanding the end-of-life process with greater openness and compassion. A key component in this change is the rise of death doulas, who offer non-medical support and guidance to individuals and their families as they navigate the final stages of life.
Death doulas share a critical commonality with the use of psychedelics for end-of-life distress in that they emphasize emotional, spiritual, and practical care. They work to demystify death, encouraging open conversations about mortality and aiding in the fulfillment of the dying person’s wishes. Again, much like psychedelic retreats for end-of-life distress, this shift represents a move away from the often sterile and impersonal experience of death in hospitals to a more personalized and dignified process that honors the individual’s life and preferences.
A Landmark Study on the Therapeutic Use of Psychedelics for End-of-Life Distress
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. This isn’t just a statement; it is both the title and conclusion of a 2016 paper by Griffiths and fellow psychedelic researcher Matthew Johnson, among others.
The researchers stated that, “Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety.” Using psychedelics for end-of-life distress works, then, by reducing the most severe kinds of emotional pain. The study authors concluded:
“High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety. At 6-month follow-up, these changes were sustained, with about 80% of participants continuing to show clinically significant decreases in depressed mood and anxiety. Participants attributed improvements in attitudes about life/self, mood, relationships, and spirituality to the high-dose experience, with >80% endorsing moderately or greater increased well-being/life satisfaction. Community observer ratings showed corresponding changes. Mystical-type psilocybin experience on session day mediated the effect of psilocybin dose on therapeutic outcomes.”

Mystical Experiences and End-of-Life Distress
The results of the 2016 study noted above raise questions about whether mystical experiences are necessary for patients to experience substantial relief from end-of-life depression and end-of-life anxiety.
Psychedelic researchers have found that the occurrence and strength of mystical experiences predict therapeutic outcomes. However, this has raised questions about precisely what it is about the mystical experience that offers patients relief from so much of their suffering.
In a popular 2015 article, published in The New Yorker, journalist Michael Pollan touched on the issue of whether mystical experiences help end-of-life distress because it leads people to believe in life after death. He asks, “Is psychedelic therapy simply foisting a comforting delusion on the sick and dying?” The philosopher Chris Letheby formulates this problem as the Comforting Delusion Objection to psychedelic therapy in his book Philosophy of Psychedelics (2020). The use of psychedelics for end-of-life distress has, therefore, led to the discussion of important ethical questions.
Letheby ultimately concludes that this objection to psychedelic therapy doesn’t hold up. This is because he believes psychedelics primarily reduce mental distress by altering people’s sense of self, not through changes to their metaphysical beliefs. However, he revised this position in a 2024 paper, published in Neuroethics, and argued that psychedelics reduce fear of death by promoting non-physicalist beliefs in patients. In other words, psychedelic therapy for end-of-life distress works by encouraging people to believe in something like life after death or our essence being part of a “Supreme Being”.
Michael Pollan’s Coverage of Psychedelics for End-of-Life Distress in How to Change Your Mind
Pollan interviewed Griffiths, along with psilocybin clinical trial patients suffering from terminal diagnoses, in his 2018 book, How to Change Your Mind, considered by many to be a catalyst in the cultural shift toward embracing psychedelic therapies.
“One of the things the psilocybin research is doing is helping open that conversation — to make people more comfortable talking about it, to get patients to actually deal with it,” said Pollan regarding his reporting on psilocybin for end-of-life distress in an interview with Time. “Oncologists don’t do a very good job of that, and we have very little for the treatment of the psychology of people who are dying. So a drug that takes you into these spiritual realms where you can begin to think it through seems to me an enormous gift.”
In How to Change Your Mind, Pollan also touched on the idea that psychedelics can offer therapeutic spiritual experiences, even if you don’t subscribe to any New Age belief:
“I could easily confirm the ‘fusion of [my] personal self into a larger whole’, as well as the ‘feeling that [I] experienced something profoundly sacred and holy’ and ‘of being at a spiritual height’ and even the ‘experience of unity with ultimate reality’. Yes, yes, yes, and yes – provided, that is, my endorsement of those loaded adjectives doesn’t imply any belief in a supernatural reality … Still, there was no question that something novel and profound had happened to me – something I am prepared to call spiritual, though only with an asterisk. I guess I’ve always assumed that spirituality implies a belief or faith I’ve never shared and from which it supposedly flows. But now I wondered, is this always or necessarily the case?”
Psychedelic Retreats for End-of-Life Distress
MycoMeditations offers therapeutic psilocybin retreats for individuals with end-of-life anxiety and end-of-life depression, along with their loved ones, to help process psychological distress during the most emotionally and spiritually challenging experience a person can endure.
What Our Guests Say About Using Psychedelics for End-of-Life Care
“Grace was diagnosed with Stage 4 Ovarian Cancer in January of 2017,” says Richard, a widower and past MycoMeditations guest. “In 2021, we identified MycoMeditations as a promising venue to experience high-intensity psychedelics in a safe, professional, and well-supported environment. The two of us attended a retreat in late October/early November of 2021. Grace’s endurance was waning, and we felt this was likely the last time she would be able to undertake such a long journey.”
“Immediately on arrival, Grace felt confident in the team and their approach. She did not speak a lot about her experiences in her journeys, indicating that they were profound but hard to articulate. This was consistent with her introspective, reflective approach to life. However, she repeatedly expressed how valuable the retreat had been. I, on the other hand, had three profound spiritual/mystical experiences. The first two of an ecstatic nature, and the third dark, confronting the depth of loss and despair that I had to date avoided while focusing on supporting Grace. On our return, we continued to identify insights derived from our journeys. Grace felt that somehow she knew what to expect. Of course, that state of certainty fluctuated over her remaining time.”
Grace passed away surrounded by her husband, a close friend, and her home care team in early 2023.
“Early one morning, she smiled, held hands with Beth, kissed me, and closed her eyes,” Richard tells us. “The palliative care nurse indicated she was likely not going to awaken, and she passed very peacefully within a few hours. Beth and I both had a sense of peace and having been present for a profound sacred moment, and had a sense of relief.”
While I clearly miss her, I both felt her presence and felt very content and blessed with having been a part of what was the best example of a “good death” that I have ever imagined. For a few months, I wondered if I was in denial and that I might be blindsided by grief. But I felt very ready to move forward, taking the step of retiring in June and registering for a second MycoMeditations retreat in September of 2023. I wanted to either reveal any hidden issues that I might need to address or confirm that I was ready to move on with my life. The psilocybin therapy retreat both supported Grace in being fully ready, welcoming her death when it came, but made it possible for me to be fully present, open, and focused throughout the process.
Since the loss of his wife, Richard has continued to communicate with the team from MycoMeditations as he positively integrates these experiences and processes his emotions.
You can hear Richard’s full story about him and Grace’s experience with psychedelics for end-of-life distress in his podcast discussion with MAPS Canada.
Discover Transformative Psychedelic Retreats for End-of-Life Distress at MycoMeditations
A terminal diagnosis does not have to be the end of all hope. While there is no right or wrong way to feel about or process one’s impending death, a sense of peace and personal insight is possible. Psilocybin for end-of-life care can be an option when other treatments don’t provide sufficient relief, or it may be considered a helpful complementary treatment alongside others.
MycoMeditations therapists are trained to manage a wide range of emotions when guiding guests through the challenging experience of navigating the topic of death.
We also know that individuals, particularly those suffering from deep, spiritual, and existential distress, must integrate psychedelic experiences within a framework of understanding that resonates with their own beliefs about self, spirituality, and religion. Our facilitators are well-versed in major religions, mythology, philosophical schools of thought, and metaphysics, enabling them to meet guests at their level in whatever way this presents itself.
Feel free to contact us if you feel a psilocybin therapy for end-of-life distress may be helpful for you or your loved ones. Our compassionate and experienced intake team can answer any questions you may have about psychedelic retreats for end-of-life distress.